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Abstract 
Alginate scaffolds show good promise for bone tissue engineering using stem cells. This is due to the 
fact that alginate is biocompatible, non-immunogenic, and in addition may direct differentiation of 
stem cells into a given phenotype. Finally, due to their ability to gel at physiological conditions, living 
and functional tissue are easily encapsulated into alginate beads.  
Alginate beads can be modified in a range of ways, not only to enhance the matrix stiffness and 
stability, but also to promote cell adhesion and direct differentiation towards a given phenotype. A 
method currently used to encourage bone growth is to mineralize the alginate beads, thus mimicking 
the structure of bone in vivo. Recently, Xie et al. (2011) demonstrated that enzymatic mineralization 
of alginate beads serves as a potent method for mineralizing beads as lower concentrations of CaCl2 
is needed, which is beneficial for cell viability. In addition, the enzymatic method produces alginate 
beads with a uniformly distribution of calcium phosphate (CP) and stiffer mechanical properties.  
Mesenchymal Stem cells (MSCs) have the potential to differentiate into a variety of tissues, including 
cartilage, adipose, muscle and bone. MSCs extracted from bone marrow seem to possess the 
greatest potential for bone tissue engineering, as they are more easily differentiated into osteogenic 
phenotypes when compared with MSCs from e.g. adipose tissue.  
The main objective in the present study was to encapsulate MSCs into alginate beads mineralized 
with alkaline phosphatase (ALP) and study cell survival, as well as their potential to differentiate into 
mature osteoblasts inside the beads. To mineralize beads (ALP) was added to the alginate solution, 
whilst the precursors were added to the growth medium. The mineralization medium was changed 
every 3 hours (12 hours over night) for the first 2 days post encapsulation. 
Cell viability was surveyed by live/dead assay and imaging by Confocal Laser Scanning Microscopy 
(CLSM), and metabolic activity by Alamar Blue (AB) and colorimetric techniques. Examination of cell 
morphology was accomplished by phalloidin/DRAQ5 staining. Moreover, to investigate cell 
differentiation, PCR analysis on selected RNA candidates was performed. Quantification of mineral 
content was accomplished by running Alizarin Red-S (ARS-S) assay. ALP activity was determined using 
ALP assay. Finally, further investigation of cell- and alginate matrix structure was accomplished using 
scanning electron microscopy (SEM).  
To study capsule properties and cell survival, osteosarcoma cells were utilized as model cells. The 
main objective was to study bead stability, and how the beads and the cells within were affected by 
the enzymatic mineralization method. Alginate beads proved to be unstable and needed addition of 
CaCl2 for stabilization purposes. Furthermore, in order to recover cells, citrate was added to the 
cell/bead suspension. Initially, results were unsatisfactory, as little, or no, RNA was recovered. After 
optimizing the citrate treatment it was discovered that a sequential method needed to be utilized. 
Results demonstrated a successful recovery of cells, and RNA of excellent quality. 
Enzymatic mineralization of alginate beads was found to be a cell friendly way of mineralizing 
alginate beads. Mineralization of beads was observed in the light microscope, by visual inspection, as 
well as by SEM. Cell viability remained high when using a concentration of 0.25mg/ml ALP. The 
osteosarcoma cells proved to be good for optimizing the enzymatic mineralization method, but 
behaved differently compared with mesenchymal stem cells in terms of viability, and mineralization 
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activity. Furthermore, mineralization of beads by addition of 0.25 mg/mL ALP compared with 
0.5mg/mL appeared to be beneficial as image acquisition on CLSM was facilitated and slightly higher 
viability of cells was observed. 
In the second part of the present study, human MSCs were encapsulated into alginate beads. After 
initial experiments the optimal condition for cell survival, and bead stability was determined. 
Consequently, in the final experiment 16 million MSCs were encapsulated in beads containing 
0.25mg/mL ALP, together with a sample without addition of ALP. At day 2 post encapsulation both 
samples were divided into two batches, one cultured in regular medium, and one in differentiation 
medium. All samples were stabilized with 7.5 mM of CaCl2. 
Observations in both light microscope and CLSM revealed that only beads given ALP were 
mineralized before reaching day 21. At day 21 the sample receiving no ALP, cultured in 
differentiation medium also appeared mineralized. 
Mesenchymal stem cells receiving differentiation medium were observed to differentiate into 
mature osteoblasts in the beads. This was verified by gene expression analysis, cell morphology 
studies, the presence of collagen in beads seen by SEM and analysis of ALP activity. Metabolic activity 
measurements confirmed little cell proliferation, nor cell death. However, an increased metabolic 
activity was observed for encapsulated cells cultured in regular medium relative to cells in 
differentiation medium. Cell morphology in differentiated samples was recognized by showing 
elongated actin filaments, compared with the ones cultured in regular medium, which appeared 
round in shape. The elongated filaments suggest that the cells are able to interact with the alginate 
matrix and/or minerals. The occurrence of collagen fibers in SEM images further confirmed presence 
of mature osteoblasts.  
Samples cultured in regular medium with or without added ALP both showed an increase in osterix 
expression until day 21 when the study was ended. This was surprising, as it inferred that the alginate 
matrix itself might influence differentiation of MSCs into osteoblasts, and that the minerals have little 
effect on differentiation. Runx2 expression was detected in all samples, including unencapsulated 
hMSCs. The expression of runx2 was at its maximum on day 21, when the study was ended. 
 
Encapsulating mesenchymal stem cells into alginate beads mineralized by the enzymatic method is 
cell friendly, and allows the cells to differentiate into mature osteoblasts when cultured in 
differentiation medium. Alginate without minerals seems to influence differentiation to a certain 
extent, suggesting that minerals are not needed for differentiation to occur. The minerals do, 
nonetheless, speed up the continuing mineralization process.  
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1. Introduction 
1.1 Background 
Alginate scaffolds show good promise for bone tissue engineering using stem cells. This is due to the 
fact that alginate is biocompatible, non-immunogenic, and may direct differentiation of stem cells 
into a given phenotype. By encapsulating cells in alginate beads for transplantation purposes the 
bead will create a protective atmosphere and prevent cellular interaction. Cells can also be more 
meticulously studied as they consistently achieve a longer lifespan in culture compared with non-
encapsulated cells. In addition one cell line can be more easily co-cultured with another without 
them interacting directly with each other (Ghidoni, 2008). 
Encapsulation of cells in gel beads serves as a potent method for both tissue engineering scaffolds 
and bone graft substitutes. These injectable scaffolds will reduce the need for invasive surgery as 
they can be injected directly into the bone defect site (Roeder, 2008). This has been demonstrated 
using different polymers, including collagen (Tsuchida, 2003) and alginate (Wang, 2003). Stem cells 
capable of differentiating into bone cells are especially interesting as they may address the 
pathological insufficiencies in an array of bone disorders, often affecting bone metabolism (Jethva, 
2009). 
Alginate beads can be modified in a range of ways, not only to enhance the matrix stiffness and 
stability, but also to promote cell adhesion and direct differentiation towards a given phenotype. 
One commonly used method is to attach peptides to the monomers creating an ECM-mimicking 
environment for the cells. Another method currently used to encourage bone growth is to mineralize 
the alginate beads, thus mimicking the structure of bone in vivo. 
Previously, mineralization of alginate beads has been achieved by an in situ one-step method. This 
means that sodium phosphates are added to the alginate solution prior to encapsulation of cells, 
whereupon calcium ions both cross-link alginate and precipitates with phosphate ions to form 
hydroxyapatite (Xie, 2010). An alternative to the one-step method is the enzymatic method. Here, 
alkaline phosphatase (ALP) is added to the alginate solution, whilst the precursors are added to the 
growth medium. Many advantages emerge with the enzymatic method. First and foremost one can 
direct the mineralization process more thoroughly by controlling the amount of enzyme and 
precursors to be added. Secondly, mineralization can be achieved using a lower ionic strength, yet 
creating beads with stiffer mechanical properties compared with the in-situ method. Finally, it has 
been demonstrated that minerals are more evenly distributed in alginate beads compared with the 
minerals formed by the one-step method (Xie, 2011). 
The latter article forms the basis for this thesis, with the main objective being to study how the 
enzymatic method influences mesenchymal stem cell` viability and differentiation inside mineralized 
alginate beads. Cell viability will be surveyed by live/dead assay and imaging by Confocal Laser 
Scanning Microscopy (CLSM), and metabolic activity by Alamar Blue (AB) and colorimetric 
techniques. Examination of cell morphology will be accomplished by phalloidin/DRAQ5 staining. 
Moreover, to investigate cell differentiation, PCR analysis on selected RNA candidates will be 
performed. Quantification of mineral content will be accomplished by running Alizarin Red-S (ARS-S) 
assay. Finally, ALP activity will be determined using ALP assay. 
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1.2 Alginate – Structure, properties and applications 
Alginate is a polysaccharide produced by some brown algae and by certain bacteria species, such as 
Azotobacter vineladii and Pseudomonas aeruginosa. Alginate extracted from seaweed has a variety 
of different applications. Today, alginates are used primarily as a thickening agent, for example in 
paint and food. Other applications include the production of many chemicals such as ethanol, 
ammonia, hydrocarbons and interferons (Smidsrod and Skjak-Braek, 1990). 
1.2.1 Structure  
Alginates are built up by two uronic acids, β-D-mannuronic acid (M) and α-L-guluronic acid (G). These 
monomers are linked through (1→4) glycosidic linkages as shown in figure 1. The M monomers exist 
in a 4C1 conformation, and the linkages between two Ms are consequently diequatorial. The G 
monomers exist in a 1C4 conformation, and the linkages between these monomers are diaxial 
(Smidsrød and Andresen, 1979).  
 
Figure 1 Alginate chain. The figure illustrates the different possible linkages between different monomers (Chaplin, 
2010). The linkage between two G monomers is diaxial, whereas the linkage between two M monomers is diequatorial. 
1.2.2 Gelling, alginate beads and encapsulation of cells 
The properties of the alginate vary greatly according to its composition. Chains of sequential G 
monomers (G-blocks) lead to the formation of a gel in the presence of divalent cations (Haug, 1961). 
Recently it has been demonstrated that, in addition, sequences with alternating M and G monomers 
(MG-blocks) may form gels (Donati, 2005). The selectivity towards G-blocks can be explained by the 
egg-box model as presented in figure 2.  
 
 
Figure 2 The egg-box model. G-blocks are built up by diaxial linkages between the G-monomers creating a zig-zag 
structure. When calcium ions are bound between these monomers they create the structure known as the egg-box 
model (McHugh, 2003). 
 3 
The calcium ion, Ca2+,  is the most commonly used cation for cross binding of alginate, although it is 
not the ion with the highest affinity for alginate (Smidsrod, 1974). This is due to the fact that Ca2+-
ions are non-toxic at low concentrations, which makes them a popular choice for cell immobilization 
purposes. As Ca2+-ions do not possess the highest affinity for alginate, the beads are not as rigid 
compared with using other ions, such as Ba2+ and Sr2+ (Smidsrod and Skjak-Braek, 1990). The stability 
of beads can be improved, for example through addition of small concentrations of Ca2+-ions to the 
culture medium. The addition of Ca2+-ions are thought to counterbalance the exchange of Ca2+ with 
Na+ and the subsequent swelling due to osmotic pressure (Martinsen et al., 1989).  
 
Several techniques exist to encapsulating live cells in gel beads, including numerous dripping 
methods for creating small beads with a narrow size distribution. Briefly, an alginate solution (~2%) 
containing cells is dripped into a calcium chloride solution, creating gel beads instantaneously, as 
illustrated in figure 3. The set up of the bead generator apparatus (needle size, voltage and flow) 
determines the size of the droplets, and hence the bead size. The properties of the gels depend also 
on other factors, including the composition and properties of the alginate. Gel beads made from 
alginate containing more than 70% guluronic acid and an average length of G-blocks longer than 15 
monomers have been demonstrated to possess the highest mechanical strength, the lowest 
syneresis and the highest porosity (Martinsen et al., 1989). 
 
Figure 3 Encapsulation of cells using the dripping method and an electrostatic bead generator. An alginate solution is 
mixed with cells inside a syringe, and dripped into a beaker containing a calcium chloride solution. The size of the beads 
can be predetermined by adjusting the settings of the bead generator apparatus, and by using alginate with a given 
composition. Modified from (Sundrønning, 2010). 
By encapsulating living cells, for instance for transplantation purposes, the alginate beads create a 
protective atmosphere from the immune system of the host (Mørch, 2009). There are several 
advantages of using alginate gels, including their biocompatibility, thermostability, simplicity of 
production and the possibility of tailoring stability, porosity and mechanical strength trough selection 
of alginate, gelling ions and formation of inhomogeneous beads. Finally, and most importantly, due 
to their ability to gel at physiological conditions, living and functional tissue are easily encapsulated. 
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There are, nevertheless, drawbacks including low stability and swelling of the gel (Skjåk-Bræk, 1991). 
The low stability becomes more predominant as cells are encapsulated within (Hwang, 2009b). This 
might be explained by the mechanical properties of the polymer being affected by the surrounding 
culture medium (Petrenko, 2011). That is, all calcium chelators will reduce the mechanical strength of 
the alginate, and some of these chelators are commonly found in the growth/ differentiation 
medium of the cells in question. These include phosphates, monovalent ions and non cross linking 
divalent ions (Berger, 1988).  
As the concentration of calcium needed to stabilize the beads is dependent on alginate origin, 
alginate composition, cross-linking density, and the calcium concentration already present in the 
medium, there is no given concentration that will stabilize any given bead (Kuo, 2008, Mørch, 2006). 
In addition, cellular growth will affect the stability, as different cell lines have been shown to 
destabilize beads, probably due to their different growth patterns (Rokstad, 2006).  
More recently studies have focused on how the cells are affected by the alginate gels. One factor 
affecting cells is the bead size which may influence cell survival, as smaller beads provides a shorter 
route for nutrient delivery (Grellier, 2009). Additionally, if cells die inside the beads they may affect 
the remaining living cells more strongly than in vivo. This might be explained by accumulation of 
waste products that are both toxic to the living cells, and obstruct the diffusion of nutrients and 
oxygen (Rokstad, 2002). In culture flasks cells are in a 2D environment. The use of beads will create a 
3D environment, resembling the in vivo extracellular matrix. This has been shown to increase 
osteogenic differentiation, probably due to the more suitable environment (Abbah, 2008). It seems 
that survival and proliferation is similar in 2D and 3D. However, differentiation into osteogenic 
phenotypes seem to be accelerated in 3D environments (Juhásová, 2011). 
Additionally, alginates and their building blocks have been shown to influence crystallization of 
calcium carbonate and calcium phosphate (Olderøy, 2009, Olderøy, 2011, Xie, 2010). In the latter 
study no mineral particles in the nano-scale were found using crystallization procedures without 
alginate. Furthermore, it has been demonstrated that the mineral phase after the crystallization 
process in alginate was similar to the mineral phase in bone (Xie, 2010). 
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1.3 Mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are stem cells capable of differentiating into a variety of connective 
tissues such as cartilage, bone, adipose and muscle as presented in figure 4 (Caplan, 1991). MSCs can 
be extracted from both adipose tissue and bone marrow. In bone marrow they exist in relatively low 
concentrations (Hwang, 2009a). In vitro, conversely, they can be easily expanded whilst preserving 
their differentiation ability (Docheva, 2008). On the downside, it usually takes weeks to yield the 
desired cell number (Panetta, 2009). MSCs from bone marrow seem to possess the greatest potential 
for bone tissue engineering, as they are more easily differentiated into osteogenic phenotypes when 
compared with MSCs from adipose tissue (Shafiee, 2011).  
Furthermore, MSCs are immunosuppressive, meaning that they create a regenerative 
microenvironment by secreting bioactive molecules, thus suppressing graft versus host disease. Due 
to this ability, allogenic MSCs have been delivered intravenously to patients suffering from various 
injuries/diseases (Caplan, 2007, Caplan, 2006). MSCs are even known to promote angiogenesis 
(Bidarra, 2010). 
 
Figure 4 Differentiation potential of human MSCs (Singer, 2011). The stem cells are capable of differentiating into a 
variety of connective tissues.  
The gene expression of MSCs changes as they differentiate into different phenotypes. Differentiation 
into osteoblasts can be monitored using methods for determining the gene expression of certain 
bone markers, specific for this lineage (Nakamura, 2007), or by simple enzyme activity detection 
(Christenson, 1997). 
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For osteoblast differentiation Runt-related transcription factor 2 (runx2), osterix (osx), alkaline 
phosphatase (alp), type I collagen (type I col), osteocalcin (ocn), osteopontin (opn) and bone 
sialoprotein (bsp) have been found to be important markers (Yao, 1994). Runx2 is a transcription 
factor that induces osteoblast differentiation early in the process, from stem cell to preosteoblast 
(Kassem, 2008). Osterix is important in later stages, where preosteoblasts differentiate into mature 
osteoblasts (Zhang, 2010). Alp and type I collagen are induced early in the differentiation and are 
important osteoblast phenotype markers. All of these genes can be detected at the RNA level using 
standard PCR technology. The expression of the runx2 and osterix at different stages during 
differentiation is given in figure 5. 
 
 
Figure 5 Expression of runx2 and osterix during differentiation from stem cell to mature osteoblast. Modified from (Lian, 
2006). Runx2 expression continues to increase throughout differentiation, whereas osterix is specific for mature 
osteoblasts. 
In addition, osteoblast differentiation can be detected by measuring ALP activity directly. This is 
accomplished  by adding a fluorescence labeled substrate for the enzyme to the cell suspension, and 
consequently measuring the fluorescent intensity (Cox, 1999). In vitro, by induced differentiation of 
MSCs, a typical ALP activity is at its maximum at day 10, before decreasing with time (Shin, 2004).  
Furthermore, some signaling molecules are known to promote the expression of the above 
mentioned genes. The most important are the BMPs, particularly BMP-2. This growth factor has been 
shown to induce bone formation through the promotion of osteoblastic lineages (Yilgor, 2010). Other 
growth factors that promote osteogenesis include VEGF, IGF-1 and FGF-2. Conversely, in excess, 
these latter growth factors will exhibit an inhibitory effect (Huang, 2010). When encapsulating MSCs 
in alginate beads the effect of growth factors on these cells may differ from the effect on cells in 
culture. This might be explained by hindered diffusion of the molecules into the encapsulated cells. 
This has been hypothesized in a previous study as it was observed that the diffusion of larger 
molecules decreased over time (Endres, 2010).  
Recently, the importance of mechanical signals (as opposed to the biochemical signals described 
above) has been discussed. For example, the shape of the MSCs will in part be determined by the 
surrounding matrix, which in turn will, to a certain degree, determine which phenotype the cell will 
express (McBeath, 2004). Other mechanical factors shown to influence the route of differentiation 
include the local matrix stiffness, fluid flow outside the cells, tension and hydrostatic pressure (Kelly, 
2010). 
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When it comes to encapsulation of MSCs into beads, studies have shown that the cells are more 
compelled to be directed towards an osteogenic phenotype inside the bead if high concentrations of 
hydroxyapatite (HA) is present (Kwei, 2010). This has been demonstrated in studies where inorganic 
HA crystallites are systematically attached to the scaffolds in use, and shown to promote osteoblast 
adhesion and protein adsorption, consequently leading to enhanced osteoblast function (Liu, 2004). 
1.4 Biomineralization  
Biomineralization is the process by which minerals are deposited in the extracellular or intracellular 
matrix, resulting in a material with both organic and inorganic constituents (Boskey, 1998). These 
materials are often strong due to the inorganic part and elastic due to the organic part.  
An example of this process is the mineralization of bone in vertebrates which occurs in two steps. 
Initially, the accumulation of Ca2+ and inorganic phosphate leads to the formation of HA in 
extracellular vesicles. These vesicles bud from the plasma membrane of all mineral forming cells and 
contain the necessary proteins for this purpose (Golub., 2009). The second step involves the 
elongation of the crystals, a process facilitated by the enzyme alkaline phosphatase (ALP). The exact 
mechanism of biomineralization by ALP on collagen was just recently discovered, although it has 
been hypothesized for some while that the enzyme acts on organic phosphate to release phosphate 
ions (Yamauchi, 2004, Tomomatsu, 2008). This was later proved after discovering that mineralization 
did not occur unless the organophosphate β-glycerophosphate was present (Spoerke, 2009). Finally, 
the crystals are deposited between collagen fibers (Orimo, 2010). The organization of HA between 
collagen fibers is illustrated in figure 6. As mentioned, much remains unknown regarding the exact 
mechanism of mineralization, but it seems that not only enzymes are involved in directing the 
mineralization, but also the extracellular matrix, i.e. collagen, at least in an in vitro system 
(Nudelman, 2010, Colfen, 2010).  
 
 
Figure 6 Organization of hydroxyapatite between collagen fibers.  In the last step of biomineralization of bone, 
hydroxyapatite is deposited between collagen fibers (Wildman, 2007). 
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1.5 Enzymatic mineralization of alginate using alkaline phosphatase 
Different strategies exist to mineralize hydrogels and scaffolds. These include the addition of 
inorganic phases, chemical modifications of the hydrogels to prevent inertia and biomimetic 
mineralization. The latter includes enzymatic mineralization where the above mentioned enzyme, 
ALP, is utilized (Gkioni, 2010). Additionally, it has been revealed that immobilized ALP in hydrogels 
made from fibrin enhance new bone formation (Osathanon, 2009).  The use of ALP to make 
HA/Collagen composites has also been demonstrated in various studies (Unuma, 2007).  
Recently, Xie et al. demonstrated that enzyme mineralization of alginate beads is favored over in situ 
mineralization for cell encapsulation, as lower concentrations of CaCl2 is needed, which is beneficial 
for cell viability. In addition, the enzymatic method produces alginate beads with an uniformly 
distribution of calcium phosphate (CP) and stiffer mechanical properties (Xie, 2011). The former may 
be explained by the uniform distribution of ALP throughout the beads as given in figure 7A. Figure 7B 
and 7C give a comparison between the mineral distributions of beads mineralized with the enzymatic 
method, and the in situ method respectively. The stiffer mechanical properties of the beads might be 
explained by the mineral distribution, as a homogeneous distribution of mineral will lead to closer 
interactions between the polymer and the minerals. 
 
Figure 7 CLSM images showing the distribution of ALP (figure A), minerals (B) in alginate beads mineralized by the 
enzymatic method using 0.1mg/mL ALP. Distribution of minerals in alginate beads mineralized with the in situ method 
(C) (Xie, 2011). The images are taken 24 hours post encapsulation, and show equatorial slices of the beads. 
Additionally, Xie et al. (2011) demonstrated that beads mineralized by the enzymatic method using 
0.5mg/ml ALP contained an estimate of 27% of minerals in the total dry weight. About 13% of the 
weight was found to be hydroxyapatite. The reminder constituted of other calcination products 
including calcium deficient hydroxyapatite and/or amorphous calcium phosphate. The mineral 
composition was dependent on pH, time and enzyme concentration, as well as the concentrations of 
the precursors (β-glycerophosphate and calcium). 
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1.6 Encapsulation of MSCs in alginate beads 
Encapsulation of hMSCs in mineralized alginate beads has previously been attempted (Sundrønning, 
2010). In this study the alginate beads were mineralized using the in situ method. Sundrønning 
encapsulated 1 million hMSCs/mL alginate solution, and mineralized the beads using 100mM of 
phosphate and 300mM of CaCl2. Post encapsulation (day 2) the viability was approximately 80% for 
all samples. A decrease in viability was observed in cells encapsulated in mineralized beads compared 
with unmineralized beads from day 11 (60% versus 80% live cells). Metabolic activity remained stable 
for both samples throughout the time of the study. Differentiation was examined using PCR 
technology. The purity of the isolated RNA was low, most probably due to DNA and/or alginate 
contamination. Genes indicating osteoblast differentiation were expressed in all samples (strong 
positive reaction), including samples neither mineralized nor given MSCDM.  
In an expanded experiment using 6 million hMSCs, Sundrønning reported a stable and slowly 
increasing metabolic activity for all samples, as given in figure 8. Live/dead assays were also 
performed, and evaluation on the CLSM indicated a gradually decreasing viability for all samples. At 
day 23 (end point) 40% of cells were alive. To test degree of mineralization Alizarin Red-S staining 
was carried out. The mineralized samples showed an increase in mineral content compared to the 
unmineralized ones, regardless of differentiation. This was further confirmed by visual inspection as 
the mineralized samples were the only ones appearing white in the light microscope. Cell 
proliferation, measured by 3H-thymidine incorporation, was observed to a small degree in all samples 
as demonstrated in figure 9.  
RNA isolated from these cells was again of poor quality. runx2 was detected in all samples (positive 
reaction) at day 3 post encapsulation. At day 7 similar results were obtained. Also non encapsulated 
hMSCs were observed to exhibit osteoblast phenotype by expressing runx2 and osterix. For all other 
samples gapdh had a relatively low Ct value
1, indicating that the cDNA concentration was low to 
begin with. Also, the high Ct values of runx2 and osterix indicates that they are present in very small 
amounts. No osterix was detected in undifferentiated samples. Ct values for every sample are given 
in table 1. 
 
 
                                                          
1
 Ct values (cycle threshold) refer to the number of PCR cycles needed to accumulate enough cDNA for it to be 
detected above background noise. The Ct value is inversely proportional to the concentration on cDNA in the 
sample. Ct values ≤ 29 indicates a strong positive reaction of the target gene. Values from 30-37 indicates a 
positive reaction. Values above 38 indicate a negative reaction that can be explained by contamination or other 
factors. 
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Figure 8  Metabolic activity of hMSCs encapsulated in alginate beads (Sundrønning, 2010). Samples include 
undifferentiated mineralized (M), differentiated mineralized (DM), undifferentiated unmineralized (UM), and 
differentiated unmineralized (DUM) beads. 
 
Figure 9 Proliferation of encapsulated hMSCs in alginate beads measured by 
3
H-thymidine incorporation. All samples 
show proliferation from day 16 to day 18 post encapsulation. Samples include undifferentiated mineralized (M), 
differentiated mineralized (DM), undifferentiated unmineralized (UM), and differentiated unmineralized (DUM) beads. 
Table 1 Ct values from PCR experiments with encapsulated in hMSCs in undifferentiated mineralized (M), differentiated 
mineralized (DM), undifferentiated unmineralized (UM), and differentiated unmineralized (DUM) alginate beads. 
Sample Target Ct Mean 
M gapdh 30.23 
M runx2 36.79 
M osterix - 
DM gapdh 31.07 
DM runx2 36.78 
DM osterix 35.07 
UM gapdh 24.88 
UM runx2 23.50 
UM osterix -- 
DUM gapdh 27.05 
DUM runx2 32.64 
DUM osterix 33.72 
hMSC runx2 20.19 
hMSC gapdh 14.85 
hMSC osterix 32.55 
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2. Materials and methods 
2.1 Alginate solution 
Ultrapure high-G alginate (UP MVG, batch: FP-505-01, Mw= 238.000 g/mol, [ŋ] = 1105 ml/g, FG= 0.67, 
FGG= 0.56, NG≥1= 13) purchased from NovaMatrix was used throughout this study. 
All equipment was thoroughly washed with alcohol (70%), and all glassware, scissors etc. had been 
sterilized by autoclaving.  
Experimental: The alginate powder was added to stirring sterile water to make a 4% alginate 
solution. NaCl (0.9 % w/v) was added to sterile water, and the two solutions were mixed and left on 
the stirrer for at least 5 hours to completely dissolve the alginate powder to a 2% solution. At this 
point the pH was adjusted to 7.2-7.4. The final solution was sterile filtered (0.2µm), and stored in a 
refrigerator until used. 
2.2 Gelling solution 
Experimental: Calcium chloride dihydrate (CaCl2 * 2H2O (50 mM)) was dissolved in sterile water. 
Following, NaCl (0.9 % w/v) and HEPES (10mM) were added. The pH of the solution was adjusted to 
the desired pH of 7.2-7.4. The solution was sterile filtered and stored in a sterile plastic bottle in a 
refrigerator until used.  
2.3 Bead preparation 
Experimental: Before encapsulation of cells in alginate beads, the enzyme ALP (12.5 or 25 µl) was 
mixed with the alginate solution (0.9mL) inside a syringe with an outer diameter of 0.35µm. After 
thorough mixing, cells in medium (0.1mL) were added, and the solution was yet again mixed. The 
syringe was mounted to an infusion pump, and attached to a needle by a plastic tube. The needle 
was set up about 2cm above the gelling solution, which was continuously stirred by a magnet stirrer. 
The electrostatic potetial was set to 7 kV and the infusion rate was 8 mL/h. The cell/alginate/enzyme 
solution was subsequently dripped into the gelling solution. After encapsulation the beads were left 
in the gelling solution for approximately 10 minutes, prior to a thorough washing in Hanks Buffered 
Salt Solution (HBSS).  
Roughly 200 mL gelling solution was used for every 1 ml of alginate/cell solution. 
For the last experiment (M4) a multihead with four syringes was set up to prevent the cells from 
being exposed to the gelling solution for a long period of time.  
Encapsulated cells were incubated at 37°C and 5% CO2. 
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2.4 Alamar Blue assay 
Principle: The Alamar Blue (AB) assay is performed to evaluate cellular health by measuring 
metabolic activity. The principle is based on the living cell´s natural reducing power as described in 
figure 2.1. The Alamar Blue dye is non toxic and very stable, and has proven to be superior to similar 
assays, such as the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay 
(Hamid, 2004). When Alamar Blue is added to a cell suspension the dye enters the cells and becomes 
reduced by electron donors such as FADH2 and NADH. This reaction results in a shift of color that can 
be correlated to the health of the cells. As the redox reaction is dependent on the metabolic state of 
the cells it cannot give an accurate measure of cell viability (Al-Nasiry, 2007).  
 
Figure 2.1 Alamar Blue assay principle. When resazurin is reduced to resorufin it produces a bright red fluorescent signal 
which in turn can be detected spectrophotometrically (Markaki, 2009).  
 
Experimental: An estimate of 5000 cells in beads was transferred to a 96 well plate. Medium from 
the culture flasks was added to the bead/cell suspension to make up a total of 180µl. Five parallels 
were prepared for each sample. As a control medium from each culture flask without beads were 
used. Alamar Blue (18µl) was added to each well, and the plate was incubated for 4 hours before 
measuring fluorescence on a multilabel counter (Victor, Perkin Elener). The readings from the control 
were subtracted from the sample measurements.  
2.5 RNA isolation, cDNA synthesis and PCR 
Principle: The gene expression of a cell can be studied by extracting its RNA, synthesize the RNA into 
complementary DNA (cDNA) and subsequently running the Polymerase chain reaction (PCR). 
Quantification can be done either absolutely or relatively. For studying the difference in gene 
expression for a given gene, the relative quantification method is adequate. In the real time-PCR (RT-
PCR) the gene is studied as it is amplified. The stronger the expression of the gene, the faster it will 
be detected. These results will be given as a cycle threshold (Ct) values. The smaller the Ct values, the 
greater the amount of target gene is present in the sample2. Using a household gene as a control, 
one can calculate the relative expression of the target gene. For this reason, RT-PCR are commonly 
used for studying the effect of a given target gene compared to an untreated sample (Livak, 2001). 
                                                          
2
 Ct values ≤ 29 indicates a strong positive reaction of the target gene. Values from 30-37 indicates a positive 
reaction. Values above 38 indicate a negative reaction that can be explained by contamination or other factors. 
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Experimental: Approximately 1 000 000 cells were transferred to a 50 mL centrifuge tube. Citrate 
(50mM, approximately 5mL- appendix A for details) was added to the cell suspension and gently 
vortexed. After dissolving the beads, the sample was centrifuged for 3 minutes at 1000 rpm and the 
supernatant removed. At this point, the solution was washed with Phosphate buffered saline (PBS), 
before a second round of centrifugation and supernatant removal. The sample was resuspended in 
PBS (200µl) before the RNA isolation step. For RNA isolation the ROCHE High Pure Isolation Kit was 
used. The isolation was performed according to the manufactures procedure. Briefly, a lysis buffer 
(400µl) was added to the cell suspension and vortexed. The sample was transferred to a “collecting 
tube” and centrifuged. A mixture of DNAse buffer (90µl) and DNAse (10µl) was added to the tube, 
the sample was centrifuged, and the supernatant removed. The sample was at this point incubated in 
room temperature for 15 minutes. Three rounds of washing were performed, before the RNA was 
eluated with an eluating buffer (60µl). A part of the sample (6µl) was taken out for OD 
determination. The rest of the sample was frozen at -80°C. 
For determination of RNA concentration and RNA quality the NanoDrop Spectrophotometer (ND-
1000 Spectrophotometer, NanoDrop Technologies Inc.) was employed. Each sample was run in three 
parallels, and the mean concentration was utilized hereinafter.  
For cDNA synthesis the High Capacity RNA-to-cDNA Kit (Applied Biosystems) was utilized. In brief, the 
isolated RNA, sterile ion free water (SIV) and a mixture of reverse transcriptase (RT) buffer and 
enzyme mix was added to an eppendorf tube and vortexed shortly. A control without RT buffer was 
also prepared. All samples were incubated at 37°C for 60 minutes before the reaction was stopped by 
increasing the temperature to 95°C for 5 minutes. The samples were put on ice and vortexed 
abruptly, before they were frozen in -20°C until used. 
RT-PCR analysis was performed using TaqMan Gene Expression Array (Applied Biosystems). Briefly, 
cDNA was diluted to the same concentration for all samples. Master Mix, probes and cDNA dilutions 
were mixed thoroughly and added to a 96 well plate in three parallels for each sample. The probes 
for detection of osteogenic phenotype were runx2 (Hs00231692_m1, lot 959159) and osterix 
(Hs00541729_m1, lot 961822). The housekeeping gene glyceraldehydes-3-phosphate dehydrogenase 
(gapdh, Hs99999905_m1, lot 853053) was used as an endogenous control. Furthermore, RT negative 
samples were prepared for each of the probes. The Applied Step One Software 2.1 was used to 
analyze the samples.  
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2.6 Live/dead assay and imaging by Confocal Laser Scanning Microscope 
Principle: Determination of cell viability can be performed by investigating certain biologic properties 
specific for either live or dead cells. In the live/dead assay two dyes are used for visualization of these 
properties, Calcein-AM and Ethidium homodimer-1 (Eth-1). Calcein-AM enters the live cells and is 
converted by esterases to calcein that produces an intense green signal, which can be detected by 
Confocal Laser Scanning Microscope (CLSM). Eth-1 will cross the membrane of dead cells only and 
bind to nucleic acids. This can be visualized by a red signal (Invitrogen, 2005). Figure 2.2 depict 
mesenchymal stem cells stained with live/dead dyes. Table 2.1 gives an overview over the settings of 
the CLSM.  
Experimental: A live/dead Viability Kit was purchased from Invitrogen. The stock solutions were left 
on the bench to warm to room temperature. A working solution was prepared by adding Eth-1 (8 µl) 
and Calcein AM (10 µl) to PBS (5 mL). The solution was vortexed to ensure thorough mixing. The 
solution was kept in a refrigerator and stored for no more than one week. Beads and medium (~0.2 
mL) were transferred to an eppendorf tube, and washed with PBS. The working solution containing 
the two dyes was added to the tube in a 50:50 relationship to the bead/PBS solution. The mixture 
was transferred to a sterile plastic petri dish, and incubated for a few minutes before imaging by 
CLSM.  
 
Figure 2.2 Mesenchymal stem cells encapsulated in alginate beads mineralized by the in situ method stained with 
calcein-AM (green) and eth-1 (red). Modified from (Sundrønning, 2010). 
Table 2.1 Settings of the CLSM for live/dead assay. 
Scan Mode;    Plane, original data, multi track, 8 bit 
Objective;    C-Apochromat 10x/0.45W 
Beamsplitters;   MBS-1: HTF UV/488/543/633 
DBS1-1: Mirror 
DBS1-2: Mirror 
NDD MBS1-1: None 
MBS-2: HTF UV/488/543/633 
DBS1-2: Mirror 
DBS2-2: NFT 545 
NDD MBS1-2: None 
MBS-3: HTF UV/488/543/633 
NDD MBS: None 
Lasers;    Argon (488nm) 
HeNe (543nm) 
Filters;     BP 505-530 
LP 650 
Pinholes;   199µm 
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2.7 Actin filament and nucleus staining using Phalloidin and DRAQ5 
Principle: Visualization of cell morphology can be performed by staining the cytoskeleton and the 
nucleus. Phalloidin bind to actin filaments in the cytoskeleton (Wulf, 1979). DRAQ5 has a high 
capacity to permeate the cell membrane, and bind to DNA with high affinity and selectivity (Smith, 
2004). Figure 2.3 depict a comparison between the morphology of an osteoblast with elongated actin 
filaments (left), and an osteoblast without elongation (right). Table 2.2 gives an overview over the 
settings on the CLSM. 
Experimental: One part bead/medium suspension was added to an eppendorf tube. The beads were 
allowed to segregate and the remaining medium was pipetted off. The beads were washed with 0.1% 
PBS/ Bovine serum albumin (BSA). Following, the cells were fixed by adding 2 parts 0.1% PBS/BSA 
with 3.7% FAH, and incubated for 15 minutes. Subsequently, the excess fixation medium was 
removed by washing with 0.1% PBS/BSA 3 times. One part Saponin in 0.1% PBS/BSA was added and 
the sample was incubated for 10 minutes in RT. Ultimately, the two dyes, Phalloidin (1 part) and 
cyto5 (1 µl) were added. After about 10 minutes the samples were washed with 0.1% PBS/BSA before 
imaging by CLSM. 
 
Figure 2.3 A mouse osteoblast (MC3T3-E1) stained by propidium iodide (red) and Phalloidin (green) inside alginate beads 
with RGD (right) and without (left). The left image shows a cell with elongated actin filaments, whereas the right image 
shows a cell without elongation. Images are taken at day 21 post encapsulation. Modified from (Evangelista, 2007). 
Table 2.2 Settings of the CLSM for cell morphology imaging. 
Scan Mode;    Plane, original data, multi track, 8 bit 
Objective;  C-Apochromat 10x/0.45W, C-Apochromat 40x/1.2W, 
C-Apochromat 63x/1.2 W 
Beamsplitters;   MBS-1: HTF UV/488/543/633 
DBS1-1: Mirror 
DBS1-2: NFT 610 
NDD MBS1-1: None 
MBS-2: HTF UV/488/543/633 
DBS1-2: Mirror 
DBS2-2: NFT 610 
NDD MBS1-2: None 
MBS-3: HTF UV/488/543/633 
NDD MBS: None 
Lasers;     Argon (488nm) 
HeNe (633nm)  
Filters;     BP 505-530 
LP 650 
Pinholes;   166µm, 212µm 
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2.8 ALP activity measurements 
Principle: ALP activity serves as a potent endogenous marker for distinguishing osteoblast phenotype 
from MSCs (Wang, 2008). Briefly, the substrate ELF-97 will fluoresce brightly upon cleavage by the 
ALP enzyme, and the enzymatic activity can thus be measured spectrophotometrically (Telford, 2001, 
Telford, 1999). 
Experimental: Approximately 10 beads were transferred to an eppendorf tube, and exposed to 
citrate (50 mM) to dissolve the beads. At this point the cells were fixated in FAH (~3.5%, 100 µl) for 
ten minutes, and subsequently centrifuged (5min, 800g, RT). Next, the cells were permeabilized by 
adding 200 µl Tween 20 in PBS (0.2%), and left in RT for 15 minutes, before another round in the 
centrifuge. At this point the cells were washed once with saline water (1 mL), incubated for 10 
minutes and centrifuged (5 min, 800g, RT). Following, the substrate (ELF-97), diluted 1:20 in the 
substrate buffer, was added to every sample (50 µl in each well). After incubation for 5 minutes the 
samples were read on a Victor plate reader, program ELF 97. 
2.9 Scanning electron microscopy 
Principle: Scanning electron microscope (SEM) is used to image cross sections of beads under greater 
magnifications then what is possible in the light microscope. For that reason the structure of the 
mineral composites can be further studied. SEM is also used to study cell morphology (Gargioni, 
2006). One major drawback is that preparations of sections involve steps that may collapse/shrink 
the samples. This is especially evident when using alginate, due to its high content of water (97%) 
(Bevan, 1995). 
Experimental: At the end of the study (experiment M4, day 21) samples were taken out of the 
culture flask and mixed with Tissue Tek (Qiagen). Following, the beads were frozen using acetone 
precooled with liquid nitrogen. The frozen beads were sectioned with a microtome (Leica CM 3050 
S). To prepare the sections for imaging they were dried in a critical point dryer (Emitech K850 Critical 
Point Dryer). Following, the dried beads were coated with platinum (80%) and palladium (20%). 
Characterization of the sections was accomplished using a scanning electron microscope.  
Sample preparation and SEM analysis were carried out by M. Xie (post doc candidate). 
2.10 Cells and cell culturing 
In initial experiments the cell line U2OS was utilized. This is a line of osteosarcoma cells derived from 
the bone tissue (tibia) of a 15 year old female who suffered from the disease.  In the main part of this 
study human Mesenchymal stem cells (hMSCs) purchased from Lonza Inc (PT 2501) were utilized. 
These cells were donated from healthy, consenting individuals. In each experiment a concentration 
of 2 million cells per 0.1 mL medium/mL alginate solution was used. U2OS cells were quantified using 
trypan blue and a coulter counter, and hMSCs were counted manually in Burker cell chambers.  
The U2OS were cultivated in cell culture flasks (75cm2) receiving RPMI 1640 medium with added 
Fetal Calf Serum (FCS, 50 mL), glutamine (2 mL) and garamycin (250 µl) making a total of 500 mL. This 
medium will henceforth be referred to as OSGM (osteosarcoma growth medium). U2OS cells 
encapsulated in alginate beads received OSGM with added CaCl2 and β-glycerophosphate during the 
mineralization process, and this medium will be referred to as OSMM (osteosarcoma mineralization 
medium). After the mineralization period the encapsulated cells received OSGM with supplementary 
CaCl2.   
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The MSCs were also cultivated in cell culture flasks of 75cm2 receiving Mesenchymal Stem cell 
Growth Medium (MSCGM, Lonza Inc, Walkerswille, MD, USA) which constitutes of Mesenchymal 
Stem Cell Basal Medium (MSCBM) with added Mesenchymal Cell Growth Supplement, glutamine and 
gentamycin. The Mesenchymal Stem cells were reseeded as few times as possible as they 
differentiation potential decreases after recurrent trypsine treatments. However, they were 
reseeded as soon as they obtained about 80 % confluence. As a rule of thumb, the MSCs for 
differentiation study purposes should not be trypsinized more than 7 times. Similar to the U2OS cells 
the MSCs received mineralization medium containing CaCl2 and β-glycerophosphate the first 48 
hours after encapsulation (henceforth referred to as MSCMM (MSC mineralization medium)), and 
subsequently MSCGM containing CaCl2.  
In experiment M4, the samples containing cells were split in two at day 2 post encapsulation. One of 
the batches received MSCGM containing CaCl2, and the other received MSCDM (MSC differentiation 
media). This includes BMP-2 (300 ng/mL, R&D Systems, Minneapolis, MN, USA), ascorbic acid (50 
mg/mL), dexamethasone (5 µl 10-4 M) and glycerophosphate (500 µl, 1M) for every 50 mL of medium. 
Furthermore, the culture flasks were changed as soon as MSCs were observed growing outside of the 
beads.  
All solutions were sterile filtered and stored in a refrigerator for a maximum of one week. 
2.11 Experiment setup 
In all experiments cells were encapsulated, and the beads were mineralized for 48 hours. Following 
mineralization the batches were given different media depending on the experiment at hand. An 
overview over the process is given in figure 2.4. Table 2.3 gives as overview over the different 
concentrations/ component utilized in each experiment. 
 
Figure 2.4 Flow sheet for experiment set up. All samples were prepared as described in the figure.  
  
t=0
• Encapsulation of cells (with/without enzyme)
t=0 - 48hrs
• Mineralization with precursors in medium                      
(medium changes every 3 hrs, except 12 hrs over night)
t= 48hrs →
• Culture in regular, substituted or differentiation medium
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Table 2.3 Experiment setup. All experiments were conducted as described above. U-experiments refers to experiments 
with the cell line U2OS, whereas M-experiments refers to experiments with hMSC-10 (experiments M1-3) or MSC-9 (M4). 
These are cell lines from two different individuals. The first 48 hours after encapsulation the medium was changed every 
3 hours (12 hours over night). 
Experiment 
number 
Cell line Medium 
(day 2 →) 
CaCl2 conc. for 
stabilization 
(mM) 
Enzyme 
concentration 
U1 U2OS OSGM 0  
0.5mg/mL 
U2 U2OS OSGM 15  
0.5mg/mL 
 
 
U3a 
 
 
U2OS 
1 OSGM 0  
 
0.5mg/mL 2 OSGM 7.5 
3 OSGM 15 
 
 
U3b 
 
 
U2OS 
1 OSGM 0  
 
0.25mg/mL 2 OSGM 7.5 
3 OSGM 15 
 
U4 
 
U2OS 
2 OSGM 7.5  
0.25mg/mL 
3 OSGM 15 
 
M1 
 
hMSC-10 
1 MSGM 7.5  
0.25mg/mL 
2 MSGM 15 
M2 hMSC-10 MSGM 7.5 0.25mg/mL 
M3 hMSC-10 MSGM 7.5 0.5mg/mL 
M4-1 None MSGM 7.5 None 
M4-2 None MSGM 7.5 0.25mg/mL 
M4-3 hMSC-9 3b MSCGM 7.5 None 
3a MSCDM 7.5 
M4-4 hMSC-9 4b MSCGM 7.5 0.25mg/mL 
4a MSCDM 7.5 
 
 
2.12 Additional methods 
Recovering cells from alginate beads was attempted several times. A description of the procedures 
and results are given in appendix A. Quantification of mineral content using Alizarin red –S was also 
attempted. Description of the experimental set up is given in appendix B. 
2.13 Statistical analysis 
A two tail Student t-test assuming equal variances was performed for assessment of statistical 
significance. A p value less than 0.05 was considered as significant. 
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3. Results 
3.1 Initial experiments with osteosarcoma cells 
To study capsule properties and cell survival, osteosarcoma cells were utilized as model cells. The 
main object was to study bead stability, and how the beads and the cells within were affected by the 
enzymatic mineralization method. The following section describes the results found during these 
initial experiments. 
3.1.1 Examination of bead stability and cell survival 
To test cell survival and capsule properties (experiment U1) cells from the cell line U20S were 
encapsulated in mineralized alginate beads as described in section 2 (Materials and methods). At day 
5 the beads were investigated in a light microscope and the result is given in figure 3.1. The beads 
appeared dark indicating mineralization. This was further confirmed as beads appeared white by 
visual inspection. However, many of the beads were cracked or ruptured completely. 
As bead stability proved to be poor, a new experiment (experiment U2) was arranged. To stabilize 
the beads 15mM of CaCl2 was added to the growth medium at day 2 post encapsulation and the 
culture flask was incubated for three days. The mineralization at day 0, day 2 and day 5 is 
demonstrated in figure 3.2. Again, mineralization was confirmed as the beads appeared dark in the 
light microscope and white by visual inspection. The mineralization process seemed to continue on 
even after the first 48 hours when cells were no longer given OSMM, as the beads continued to get 
darker in the light microscope. Furthermore, addition of CaCl2 stabilized the beads as they were all 
intact.  
At day 2 and 5 the number of intact beads was estimated by counting 100 beads. An evaluation of 
cell viability was performed by using live/dead assay and CLSM. The results are presented in table 
3.1. Images from CLSM are presented in figure 3.3. Most cells survived the encapsulation process, 
seen at day 0, and the following mineralization, seen at day 2 post encapsulation. However, as the 
mineralization process progressed, viability decreased. Additionally, the heavily mineralized beads 
made CLSM image acquisition difficult. This might be explained by the density of minerals in the core 
of the bead. At day 5 only the cells in the outer part of the beads were visible, making it hard to 
estimate the viability correctly. 
To test RNA quality the beads were dissolved in citrate, washed with PBS and the cells were counted. 
At this point almost all cells were gone. As an explanation for the great cell loss was not found, 
further studies were performed in order to optimize the citrate treatment. All results from the citrate 
treatment optimizing process are given in appendix A.  
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Figure 3.1 Osteosarcoma cells encapsulated in alginate beads given 0.5mg/mL ALP (experiment U1) at day 5 post 
encapsulation. About 80 % of the beads are broken and/or completely dissolved. 
 
 
Figure 3.2 Osteosarcoma cells encapsulated in alginate beads given 0.5 mg/mL ALP (experiment U2) at day 0, day 2 and 
day 5 post encapsulation, respectively. 15mM of CaCl2 was added to the culture medium to stabilize the beads at day 2 
post encapsulation. 
Table 3.1 Viability and number of intact beads at day 0, 2 and 5 post encapsulation. The beads were given 0.5 mg/mL 
ALP. The beads were stabilized by adding 15mM of CaCl2 to the culture medium. 
Day (post encapsulation) Viability (%) Intact beads (%) 
0 97 100 
2 75 98 
5 55 98 
   
 
 
 
 
 
 
 
 
Figure 3.3 CLSM pictures of U2OS cells encapsulated in alginate beads given 0.5 mg/mL ALP. Beads were stabilized by 
adding 15mM CaCl2 to the culture medium. Left picture: CLSM cross section. Right picture: CLSM Z stacks 3D projection of 
the same beads. Live cells are indicated by a green color, whereas red cells are dead. Magnification: 100X.   
Alginate beads given 0.5mg/mL ALP 
 
 
 
 
 
Day 2   
 
 
 
 
 
 Day 5   
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3.1.2 Extended experiment of osteosarcoma cells in mineralized beads 
It was hypothesized that the beads became brittle from the fast mineralization process. This was 
likely caused by continuous production of phosphate ions by ALP, which precipitated with Ca2+-ions 
in the gel, thereby destabilizing the alginate cross-links. For that reason a new experiment 
(experiment U3) was set up with the goal of comparing bead stability and cell survival in beads given 
different ALP concentrations. Seeing that addition of 15mM CaCl2 improved bead stability this was 
repeated in the experiment at hand. However, as high concentration of CaCl2 may affect cell viability, 
the sample was split in three at day 2. One batch was given no CaCl2, one 7.5mM CaCl2 and one 
15mM CaCl2 to uncover at what concentration viability was favored.  
The beads from the two batches with different enzyme concentrations were monitored, and light 
microscope pictures were taken during the mineralization process. The results are given in figure 3.4.  
All beads were mineralized at day 2 post encapsulation, regardless of enzyme concentration. The 
beads given 0.5mg/mL ALP appeared darker compared with the beads given 0.25mg/mL, suggesting 
that they were more mineralized. The images are all from batches stabilized with 15mM CaCl2. All 
beads remained intact in these batches. This was not the case for batches with less, or no addition of 
CaCl2. 
For that reason, bead stability was examined by counting 100 beads. Figure 3.5 compares how the 
stability of the different beads was influenced by different calcium concentrations. It seemed that 
bead stability was superior in beads stabilized with 7.5 or 15mM CaCl2 as most of the beads remained 
intact reaching day 8 post encapsulation. At this point beads in batches without addition of CaCl2 
were all gone. Comparing the two batches of beads added different concentrations of CaCl2, addition 
of 15mM seemed to give a slightly increased stability. Furthermore, enzyme concentration seemed 
to affect stability as well.  Stability of beads given 0.25mg/mL ALP was superior compared to those 
given 0.5mg/mL ALP. 
 Beads mineralized by the enzymatic method 
 
 
 
 
 
Day 0        
 0.5 mg/mL ALP 0.25 mg/mL ALP 
 
 
 
 
 
Day 4   
 
 
 
 
 
Day 7   
Figure 3.4 Light microscope pictures at day 0, 4 and 7 post encapsulation from beads given 0.25mg/mL and 0.5mg/mL 
ALP. Beads were stabilized with 15mM CaCl2. Image magnification: 40X. 
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Figure 3.5 A comparison of bead stability in beads given 0.25mg/mL, and 0.5mg/mL ALP respectively, and between the 
two batches given different calcium concentrations in the culture medium (0, 7.5 and 15mM, respectively). 
CLSM images from the experiment are given in figure 3.6 and 3.7. As no, or only 22%, of the beads 
remained intact at day 4 post encapsulation in medium without addition of CaCl2, no further 
live/dead assays were performed on these samples. 
It appeared to be a slight tendency to augmented cell survival in beads given 7.5mM CaCl2 for 
stability over the ones given 15mM. Cell survival in beads mineralized with different concentrations 
of ALP appeared to be fairly equivalent, although the survival seemed to be higher in beads given 
0.25 mg/mL ALP until reaching day 9 post encapsulation. 
As beads became increasingly mineralized, difficulties arose regarding image acquisition. The viability 
estimates after day 2 post encapsulation are consequently uncertain, particularly in beads given 0.5 
mg/mL ALP. 
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Figure 3.6 CLSM images of U2OS cells encapsulated in alginate beads given 0.5 mg/mL ALP. Samples were cultured in 7.5 
and 15 mM CaCl2 from day 2 to day 13 post encapsulation. Right picture: CLSM Z stacks 3D projection of the same beads. 
Live cells appear green, whereas dead cells appear red. All images were magnified 100X. 
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Figure 3.7 CLSM images of U2OS cells encapsulated in alginate beads mineralized using 0.25 mg/mL ALP.  Samples were 
cultured in 7.5 and 15 mM CaCl2 from day 2 to day 13 post encapsulation. Right picture: CLSM Z stacks 3D projection of 
the same beads. Live cells appear green, whereas dead cells appear red. All images were magnified 100X. 
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3.2 Initial experiments with mesenchymal stem cells 
Before initializing an extensive experiment, preliminary experiments were carried out in order to 
determine whether the MSCs would behave in a similar fashion as the osteosarcoma cells inside the 
mineralized alginate beads. The following sections describe results obtained during these initial 
experiments. 
3.2.1 Mineralization with 0.25mg/mL ALP 
From initial experiments with osteosarcoma cells it appeared that addition of CaCl2 to the basal 
medium after day 2 post encapsulation helped stabilizing the beads. Furthermore, mineralization of 
beads by addition of 0.25 mg/mL ALP compared with 0.5mg/mL appeared to be beneficial as image 
acquisition on CLSM was facilitated and slightly higher viability of cells was observed. 
Consequently, MSCs were encapsulated in beads given 0.25mg/mL ALP (experiment M1). At day two 
the MSCMM was changed to MSCGM with 7.5mM/15mM of added CaCl2. Figure 3.8 gives light 
microscope pictures of the beads at different time points during the mineralization and culture. From 
the figure it is apparent that the MSCs cluster inside the beads. This is a known tendency for MSCs 
and may influence the result of the present study. From a cell survival point of view, the clustering 
may be beneficial, as cells may support each other. The clustering may, however, camouflage the 
effect of the matrix material efficiency of supporting the cells inside the matrix. 
The mineralization process in beads with MSCs also seemed to differ somewhat from the 
mineralization process in beads with U20S. In beads with MSCs it seemed that the mineralization 
starts in the core of the bead rather than in the outskirts, as was observed in experiments with 
osteosarcoma cells. Also, the degree of mineralization is rather low compared to the experiments 
with osteosarcoma cells.  
                         Beads given  0.25 mg/ml ALP 
 
 
 
 
 
Day 0 
 
 7.5 mM CaCl2 15 mM CaCl2 
 
 
 
 
 
Day 4   
 
 
 
 
 
Day 7   
Figure 3.8 Light microscope pictures of encapsulated MSCs in beads mineralized with 0.25 mg/mL ALP. At day 2 post 
encapsulation the sample was split in two, and given different CaCl2 concentrations. Images are magnified 40X. 
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At day 2, 4 and 7 post encapsulation live/dead assays were performed. The results are given in figure 
3.9. Cell viability remained high throughout the experiment.  
 
Figure 3.9 CLSM pictures of MSCs encapsulated in alginate beads given 0.25 mg/mL ALP. At day two the sample was split 
in two and added CaCl2 in different concentrations. Left picture: CLSM cross section. Right picture: CLSM Z stacks 3D 
projection of the same beads. Live cells appear green, whereas dead cells appear red. All images were magnified 100X. 
At day 7post encapsulation the cells were attempted recovered by dissolving the beads with citrate, 
and RNA isolation analysis was subsequently performed (see Appendix A.5 for details).  
As the beads were mineralized to a smaller extent compared with experiments with osteosarcoma 
cells, a new experiment (M2) was set up where a freshly made enzyme was utilized. Images from the 
mineralization process are given in figure 3.10.  
 
 
Figure 3.10 MSCs encapsulated in alginate beads mineralized with 0.25mg/mL ALP at day 0 and day 2 post encapsulation, 
respectively. The beads were stabilized by adding 7.5mM CaCl2 to the culture medium. Images are magnified 40X. 
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3.2.2 Mineralization with 0.5mg/mL ALP 
Considering that addition of 0.25mg/mL ALP did not mineralize the beads as much as expected, the 
enzyme concentration was increased again (experiment M3). Images from the mineralization process 
with the elevated enzyme concentration are given in figure 3.11. Again, the minerals appeared to be 
centered in the core of the bead. As for the experiments with osteosarcoma cells, the beads seem to 
be further mineralized even after day 2 post encapsulation. Increasing the concentration of ALP 
appeared to increase the mineralization process as the beads appear darker than in the experiments 
where 0.25mg/mL ALP was utilized.  
At day 8 post encapsulation the morphology of cells inside beads was investigated by staining the 
actin filaments and the nucleus. Images from CLSM are given in figure 3.12. From the picture to the 
right the cells appear to interact with each other as their actin filaments seem to elongate toward 
each other. Again image acquisition was difficult as the beads were heavily mineralized, making the 
cells in the core of the bead invisible in the microscope.  
At day 2 and 5 post encapsulation the viability of the cells were investigated using live/dead assay 
and CLSM. The images are given in figure 3.13. It seems that the MSCs were as viable inside beads 
given 0.5mg/mL ALP compared to the ones prepared with 0.25mg/mL ALP showing high viability 
throughout the 8 days of culture. Conversely, image acquisition by CLSM was more intricate. As a 
result, it is hard to say if cells in the core of the bead are alive or dead. 
 
 
Figure 3.11 MSCs encapsulated in alginate beads mineralized with 0.5mg/mL ALP at day 0, day 2 and day 5 post 
encapsulation, respectively. The images are magnified 40X. 
Day 8  
Figure 3.12 CLSM images of the morphology of cells inside beads mineralized with 0.5mg/mL ALP on day 8 post 
encapsulation. Left picture: CLSM cross section. Right picture: Cross section. The nucleus appears red, whereas the actin 
filaments appear green. Left image is magnified 100X, whereas the right image is magnified 400X. 
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Day 2    
Day 5     
Day 8     
Figure 3.13 CLSM pictures of MSCs encapsulated in alginate beads mineralized with 0.5 mg/mL ALP. Left picture: CLSM 
cross section. Right picture: CLSM Z stacks 3D projection of the same beads. Live cells appear green, whereas dead cells 
appear red. The samples were magnified 100X. 
Finally, at day 9 post encapsulation, beads containing roughly 1 million cells were dissolved in citrate, 
and RNA was extracted from the cells. In table 3.2 the concentration and purity of the isolated RNA 
are listed. The purity of the RNA was good as the OD 260/280 > 2. After cDNA synthesis the 
expression of runx2, an osteoblast phenotype marker was quantified using RT PCR. The mean Ct 
values and relative gene expression are given in table 3.3 and figure 3.14, respectively. gapdh was 
used as an endogenous control. The confirmed expression of runx2 suggests that the encapsulated 
MSCs had the potential to differentiate into preosteoblasts. 
 
Table 3.2 RNA isolation. The table gives information regarding amount of RNA isolated, and the purity of the RNA. 
OD260/280> 2, indicating that RNA quality is good.  
Sample Day (post enc.) Concentration of RNA (ng/µl) Amount of RNA 260/280 
1 9 66.9 3.6 2.02 
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Table 3.3 Mean Ct values of samples from encapsulated MSCs in beads mineralized with 0.5mg/mL ALP. gapdh was used 
as a endogenous control, whereas runx2 is an osteoblast specific gene. Controls (samples without RT, or without cDNA) 
were both negative. 
Sample Mean Ct 
gapdh 23.5 
runx2 29.8 
 
 
Figure 3.14 Relative expression of runx2 in MSCs encapsulated in alginate beads mineralized with 0.25mg/mL ALP. Error 
bars are +/- 1 SD. 
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3.3 Extended experiment using 0.25mg/mL ALP 
As a final experiment 16 million MSCs were encapsulated in alginate beads, containing 0.25mg/ml 
ALP (samples 4a/b) and containing no ALP (samples 3a/b). Half of each batch was given 
differentiation medium (samples 3a/4a) starting at day 2 post encapsulation. Alginate beads without 
cells were also prepared, not containing ALP (sample 1), and containing ALP (sample 2), making the 
total of 6 batches. At day 2, 7, 9, 14 and 21 post encapsulation beads and cells were tested using an 
array of analysis as described in the following sections. 
Before and after the mineralization process (day 0 to day 2 post encapsulation) light microscopy 
pictures were taken of the different samples. There were only four samples at this point as they had 
not been split for differentiation purposes up till now. The images are displayed in figure 3.15. 
At day 0 post encapsulation all beads looked the same with no mineralization as expected, and 
appeared to be similar in size. Also, cells seemed to be homogeneously distributed between the 
beads. Inside the beads, some of the cells were clustered together.  
At day 2 post encapsulation samples receiving ALP enzyme appeared to be slightly mineralized as 
they appeared darker in the light microscope. Visual inspection confirmed this, as the beads 
appeared white. The degree of mineralization seemed to differ somewhat between the beads, 
indicating that the enzyme, and/or phosphate/calcium-ions were not homogeneously distributed in 
the culture flask.  
The mineralization seemed to continue after the initial 48hrs were the samples were given calcium 
phosphate precursors. This was observed in the light microscope as shown in figure 3.16. These 
images were collected at day 21 post encapsulation. At this point sample 3a (no ALP, but given 
differentiation medium) also appeared to be mineralized. Sample 3b was the only sample not 
mineralized, which was expected, as these cells were neither given differentiation, nor mineralization 
medium.  
Furthermore, sample 4a was more mineralized than sample 4b even though both samples received 
the same concentrations of ALP.  
 
Figure 3.15 Light microscope images of beads at day 0 and day 2, post encapsulation. Top: Beads at day 0. From the left; 
beads without enzyme and cells (Samples 1); beads with enzyme but without cells (sample 2); beads without enzyme but 
cells (sample 3); beads with enzyme and cells (Sample 4). Bottom: Beads at day 2. Images are magnified 40X. 
 31 
Figure 3.16 Light microscope pictures from day 21 post encapsulation. Sample 3a is without enzyme but with added 
differentiation medium; sample 3b is with enzyme, but without differentiation medium; sample 4a is given both enzyme 
and differentiation medium, whereas sample 4b is without enzyme and differentiation medium. All images are magnified 
40X.  
 
3.3.1 Live/dead and CLSM 
At day 2, 7, 14 and 21 post encapsulation the survival of MSCs encapsulated in alginate beads was 
evaluated using live/dead assay and CLSM. The results are given in figure 3.17 and 3.18. It seemed 
that MSC survival was good inside the beads as viability remained <90%. No obvious difference 
between samples given differentiation medium (samples 3a/4a) and samples not given 
differentiation medium (3b/4b) was observed. Furthermore, the viability of cell seemed to be 
unaffected by the mineral content of the beads.  
Cells inside beads seemed to have proliferated from day 7 to day 14 as cell clusters were more 
frequently observed at day 14 compared to day 7. This was especially evident in both unmineralized 
and mineralized beads not exposed to differentiation medium. The proliferation seemed to have 
stopped after day 14 as the clustering did not continue.  
At day 21 beads not containing ALP but receiving differentiation medium seemed to be mineralized 
as they appeared darker in the microscope. This confirmed the observations made from the light 
microscope pictures. 
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Figure 3.17 CLSM pictures of MSCs encapsulated in alginate beads not containing ALP. Left picture: CLSM cross section. 
Right picture: CLSM Z stacks 3D projection of the same beads. Live cells appear green, whereas dead cells appear red. All 
samples are magnified 100X. 
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Figure 3.18 CLSM pictures of MSCs encapsulated in alginate beads containing 0.25 mg/mL ALP. Left picture: CLSM cross 
section. Right picture: CLSM Z stacks 3D projection of the same beads. Live cells appear green, whereas dead cells appear 
red. All samples were magnified 100X. 
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3.3.2 Alamar Blue 
Alamar Blue analysis was completed to measure the cells metabolic activity. Measurements were 
performed at day 2, 7, 14 and 21 post encapsulation and the results are given in figure 3.19.  
The metabolic activity increased over time for all four samples, which indicated good cell viability, 
and little occurrence of cell death. All samples showed an increase in metabolic activity between day 
7 and 14 which was also reflected in the live/dead assay previously described. This might be 
explained by cell proliferation. The increase in samples receiving differentiation medium might be 
explained by them differentiating into osteoblasts. 
 
Figure 3.19 Alamar Blue assay results for hMSCs in alginate beads. The errors bars represent the standard deviation for 
every reading based on three parallels. The absorbance values are based on 5000 cells. Sample 3 is not containing ALP 
and exposed to differentiation medium (3a) or to regular culture medium (3b); sample 4 is containing ALP and exposed 
to differentiation medium (4a) or to regular culture medium (4b). 
 
3.3.3 Morphology of cells inside beads 
Morphology of the cells inside the alginate beads were investigated by staining their nucleus and 
cytoskeleton. Images from CLSM are shown in figure 3.20 and 3.21. At day 2 post encapsulation, the 
cells were round and no specific organization of the actin filament could be observed. The cells 
appeared to possess more elongated actin filaments already at day 7 in samples receiving 
differentiation medium. Cells without addition of differentiation medium seemed to obtain their 
original round shape throughout the time of the study. Thus, the samples given differentiation 
medium were the only ones establishing interaction with the alginate matrix. 
Mineralization of the alginate beads seemed to have little effect on cell/matrix interactions, as no 
difference was observed between samples with, or without addition of ALP.  
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Figure 3.20 CLSM images of cell morphology inside alginate beads without ALP stained with phalloidin (green) and 
DRAQ5 (red). Elongated filaments are marked with an arrow. The size bar is 20µm. Left pictures are magnified 100X. 
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Figure 3.21 CLSM images of cell morphology inside alginate beads stained with phalloidin (green) and DRAQ5 (red). 
Elongated filaments are marked with an arrow. The size bar is 20µm. Left pictures are magnified 100X. 
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3.3.4 ALP activity 
ALP activity was measured on day 2 and day 9 post encapsulation. This means at day 0 and day 7 
after initializing differentiation by addition of differentiation medium. The results are given in figure 
3.22 and 3.23 for day 2 and day 9, respectively. At day 9 post encapsulation samples 3a and 4a were 
the two samples showing the greatest increase in ALP activity from t=0 to t=20. The differences 
between activity at t=20 for samples with and without differentiation medium are statistically 
significant (p<0.01 and p<0.002 for samples 3a/b and 4a/b, respectively). From the figures below it 
seems to be an increase in ALP activity from t=0 to t=20 in both sample 3 and 4 at day 2. This is 
surprising as differentiation medium had not yet been introduced, and sample 4 is the only sample 
with added enzyme. No statistically significant difference was observed between these samples. 
 
Figure 3.22 ALP acitivity at day 2 post encapsulation. Fluorescense intensity was measured every minute for 20 minutes, 
The first (t=0) and the last (t=20) measurement are given in the histogram (n=3 ± 1 SD). Sample 3 did not contain external 
ALP, whereas sample 4 contained ALP from the day of encapsulation. Sample 1 was neither given ALP nor containing 
cells, and was used as a control.  
 
Figure 3.23 ALP acitivity at day 9 post encapsulation/day 7 post differentiation. Fluorescense intensity was measured 
every minute for 20 minutes, The first and the last measurement are given in the histogram (n=3 ± 1 SD). Sample 3a was 
without external ALP, but given differentiation medium; sample 3b was without ALP and without differentiation 
medium; sample 4 was given ALP and differentiation medium; sample 4b was given ALP but not differentiation medium. 
Sample 1 contained neither ALP or cells; sample 2 contained ALP but not cells. The two latter were used as controls. 
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3.3.5 PCR analysis of runx2 and osterix 
RNA was isolated at day-1 (one day before encapsulation start), day 2, 7, 14 and 21 post 
encapsulation. At day -1 cells that had never been encapsulated were used. For the remaining days 
beads corresponding to approximately 1 million cells were isolated using citrate treatment to recover 
cells from beads. Table 3.4 gives an overview over total amount of isolated RNA and its purity from 
all samples.  
Nearly all samples were considered to consist of pure RNA, as their OD260/280 ratios were > 2.  All 
calculations were based on the mean of three parallels. Next, PCR analysis was performed using 
probes (runx2 and osx).  
Table 3.4 RNA isolation results. Samples of pure RNA (no contamination) will obtain an OD260/280 ration above 2. Sample 
0 is unencapsulated hMSCs; sample 3 was not given enzyme nor differentiaion medium, sample 4 was given enzyme 
without differentiation medium; sample 3a was not given external ALP, but given differentiation medium; sample 3b was 
without ALP and without differentiation medium; sample 4 was given ALP and differentiation medium; sample 4b was 
given ALP but not differentiation medium. n=3. 
Sample Day  
(Post encapsulation) 
Concentration of RNA 
(ng/µl) 
Amount of RNA 
(µg) 
OD260/280 
0 -1 822.6 44 2.06 
3 2 283.0 15 2.01 
4 2 222.4 12 2.03 
3a 7 140.2 7.6 2.10 
3b 7 114.1 6.2 2.09 
4a 7 106.5 5.8 2.08 
4b 7 45.7 2.5 1.95 
3a 14 74.0 4.0 1.98 
3b 14 112.2 6.1 2.03 
4a 14 50.7 2.7 2.02 
4b 14 175.6 9.5 2.04 
3a 21 16.4 0.9 1.49 
3b 21 131.9 7.1 2.04 
4a 21 64.6 3.5 2.05 
4b 21 119.2 6.4 2.06 
 
Amplification plot and relative expression of runx2 in all samples are given in figure 3.24 and 
3.25.The amplification plot reveals a strong positive reaction for runx2 in all samples, as the Ct values 
are all below 29.   
runx2 was expressed by hMSCs pre encapsulation. This was not surprising as MSCs are known to 
express runx2 at low levels. At day 2 post encapsulation both samples with and without enzyme had 
comparable expression as the MSCs from day -1. At day 2 the samples were split in two and given 
differentiation or regular medium. All of these samples showed an increase in expression at day 7 
compared with day 2. The samples given differentiation medium (3a/4a) showed a stronger 
expression at day 7 and day 14 compared with samples given regular medium (3b/4b). The former 
samples continued to hold a high runx2 expression throughout the time of the study. Sample 4b 
shows a gradually increasing expression, whereas sample 3b showed a decrease from day 7 until day 
21 when the study was ended. 
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Figure 3.24 Amplification plot of runx2. The curve gives as impression of the Ct values for all gapdh (purple) and runx2 
(blue), at the point where the curves cross the threshold at y=1. Ct values ≤ 29 indicates a strong positive reaction of the 
target gene. Values from 30-37 indicates a positive reaction. Values above 38 indicate a negative reaction that can be 
explained by contamination or other factors. Gapdh was used as an endogenous control. 
 
Figure 3.25 Relative expression of runx2 in unencapsulated hMScs and samples at day -1, 2, 7, 14 and 21 post 
encapsulation. The concentrations are normalized against unencapsulated hMSCs. Sample 3a was without external ALP, 
but given differentiation medium; sample 3b was without ALP and without differentiation medium; sample 4 was given 
ALP and differentiation medium; sample 4b was given ALP but not differentiation medium. Sample 1 contained neither 
ALP or cells; sample 2 contained ALP but not cells. The two latter were used as controls. 
Amplification plot and relative expression of osterix are given in figure 3.26 and 3.27. The 
amplification plot reveals a positive or strong positive reaction for osterix in all samples, as the Ct 
values are all below 37. MSCs did not show any expression of osterix.    
osterix expression varied greatly between samples given differentiation medium and regular 
medium. Mineralization seemed to not affect differentiation as no difference was observed between 
samples that contained ALP and samples without ALP. Detection of osterix in all samples started at 
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day 2 post encapsulation, which was unexpected as osterix is considered a late marker for osteoblast 
differentiation. Expression of osterix seemed to increase in all samples throughout the study (from 
day 7 to day 21 post encapsulation), with the exception of sample 3a, where a subtle decrease in 
observed between day 14 and day 21. 
 
Figure 3.26 Amplification plot of osterix. The curve gives as impression of the Ct values for all gapdh (purple) and osterix 
(blue), at the point where the curves cross the threshold at y=1. Ct values ≤ 29 indicates a strong positive reaction of the 
target gene. Values from 30-37 indicates a positive reaction. Values above 38 indicate a negative reaction that can be 
explained by contamination or other factors. Gapdh was used as an endogenous control. 
 
Figure 3.27 Relative expression of osterix in unencapsulated MScs and samples at day -1, 2, 7, 14 and 21 post 
encapsulation. The concentrations are normalized against unencapsulated hMSCs. Sample 3a was without external ALP, 
but given differentiation medium; sample 3b was without ALP and without differentiation medium; sample 4 was given 
ALP and differentiation medium; sample 4b was given ALP but not differentiation medium. Sample 1 contained neither 
ALP or cells; sample 2 contained ALP but not cells. The two latter were used as controls. 
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3.3.6 SEM images 
At day 21 post encapsulation the remaining beads were prepared for SEM analysis. The results are 
given in figure 3.28. The alginate matrix seemed to be more porous in sample 3b compared to the 
rest of the samples. Sample 4a appeared mineralized as mineral composites were observed.  Sample 
4b seemed to be more mineralized compared with samples not given ALP (sample 3a/3b). 
Nevertheless, no obvious granules were observed in these three samples. The cells within beads 
given differentiation medium (3a/4a) appeared to have elongated actin filaments, confirming the 
observations seen on the CLSM. However, sample 3a seemed to be far more stretched compared to 
sample 4a. Additionally, sample 4b (given ALP, but not differentiation medium) seemed to interact 
with the matrix as well. Furthermore, there seemed to be a void between the cells and alginate 
matrix. This might be explained by shrinkage of the alginate during the preparations for SEM analysis.  
3a  
3b  
4a  
4b  
Figure 3.28 SEM images of the alginate matrix (left), and cells within (right). Sample 3a is without enzyme but with added 
differentiation medium; sample 3b is with enzyme, but without differentiation medium; sample 4a is given both enzyme 
and differentiation medium, whereas sample 4b is without enzyme and differentiation medium. Left magnification: 20 k, 
right magnification: 4.5 k. 
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In samples with added differentiation medium, collagen fibers were observed. Magnifications of the 
collagen are given in figure 3.29. The image to the right clearly shows a lot of fibers around what 
seems to be a MSC. To the left a magnification of these fibers are given.  
 
In the mineralized samples the collagen seemed to be penetrating the matrix, compared with the 
unmineralized samples where the cells seemed to deposit collagen in a capsular way. In figure 3.30 
the collagen fibers were observed interacting with both the mineral composites, and the alginate 
matrix.  
 
  
Figure 3.29 SEM images of collagen around a cell (left), and magnification of the collagen fibers (right). The samples were 
taken out of the culture flask at the end of the study (day 21). Images are from sample 3a (unmineralized, differentiated). 
Left image: 5.0 k magnification, right image: 100 k magnification. 
 
Figure 3.30 Collagen fibers interacting with both mineral composites, and the alginate matrix. The collagen was observed 
in sample 4a, which is given ALP and differentiation medium. Magnification: 20 k. 
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4. Discussion 
4.1 Bead stability 
In initial experiments with osteosarcoma cells beads were mineralized using 0.5mg/mL ALP. The 
beads were rapidly and heavily mineralized appearing very dark in the light microscope at day 2 post 
encapsulation. After the first 48hours of continuous changing mineralization medium, the beads 
were cultured in regular medium. At this point the beads cracked open, and the majority were 
completely dissolved at day 5, post encapsulation (figure 3.1). The observation of decreasing bead 
stability subsequent to changing the mineralization medium into growth medium needed to be 
further study. For that reason addition of CaCl2 to the regular growth medium was attempted, using 
different concentrations. 
A possible explanation for the destabilization could be that the beads became brittle after the fast 
mineralization process, and thereby become ruptured by handling. However, as the medium changes 
in the mineralization process are far more frequent, this is not likely. Furthermore, compression 
measurements by Minli et al (2010) show that ALP mineralized alginate beads are elastic, but with a 
high resistance towards compression, confirming these observations. 
As the beads remained intact after addition of CaCl2 to the growth medium, it seemed that the low 
stability was due to other reasons. A probable cause could be that CaCl2 was the limiting reagent in a 
continuing mineralization of the beads, whereby Ca-alginate crosslinks were broken as Ca-ions were 
used to generate calcium phosphate by reacting with the phosphate in the culture medium. Also, the 
medium contains calcium chelators (phosphate and carbonate) that may explain the reduced 
mechanical strength of the beads. Taken together, both of these postulations ought to be solved by 
adding more calcium to the medium, which was also the case. 
Additionally, bead stability decreased more quickly as the ALP concentrations utilized for 
mineralization increased. This supports the presumption that CaCl2 was the limiting reagent as the 
more mineralized the beads became; the more CaCl2 was required for stabilization purposes.  
Moreover, rapidly proliferating cells such as osteosarcoma cells may further decrease bead stability. 
Indeed, it was observed that bead stability was poorer in the experiments with osteosarcoma cells 
compared with experiments with MSCs. As osteosarcoma cells are rapidly proliferating they might be 
more potent in inducing mineralization, thus consuming Ca-ions more rapidly compared with MSCs. 
Again, this would cause loss of Ca-alginate cross-links, thus destabilization of the beads. It seems that 
the different growth patterns in different cell lines affect the destabilization process. 
Furthermore, in experiments running over a longer period of time (over 14 days) cells were 
frequently observed growing outside the beads. Cells escaping from alginate/poly-L-lysine/alginate 
beads have been previously reported for osteosarcoma cells, and was suspected of being the cause 
of bead rupture (Rokstad, 2002). In the present study the penetrations of cells did not cause bead 
rupture, as long as Ca-ions were present in excess in the culture medium. MSCs seemed to penetrate 
the beads to a lesser extent compared with the osteosarcoma cells. An explanation could be that the 
MSCs were observed to cluster inside the beads, thus being less likely to tear away from the matrix. 
Major drawbacks caused by the low stability were the difficulties in running certain experiments. For 
CLSM imaging the beads seemed to crack open if left too long in PBS/live/dead solution. Alizarin Red-
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S was also affected as all beads cracked open during the experiment, as described in appendix B. 
Bead instability could possibly be overcome by the addition of CaCl2 to all handling solutions. 
Nevertheless, precipitation of CP in phosphate buffers limits this, and other buffers might have been 
selected. Furthermore, when it comes to Alizarin Red-S addition of Ca-ions would affect results, as 
calcium is the component to be quantified.  
Compared with the in situ mineralization method described in the introduction it seems that stability 
is poorer when using the enzymatic method. It was reported that the beads remained intact 
throughout the time of the studies (up to 30 days), without stabilizing them with Ca. However, the 
beads were observed to crack open if left too long in PBS (Sundrønning, 2010). This is explained by 
the phosphate ions, which acted as calcium chelators.  
Nevertheless, bead stability may offer some advantages. The poor stability might give alginate the 
possibility to be degraded in the body. Today, alginate is not known to be degraded in vivo, without 
modifications, such as gamma-irradiation (Simmons, 2004). Thus, the beads in the present study 
could be directly implanted into a bone fracture side, to be gradually degraded revealing the cells 
within. Alginate would be degraded in the body as the concentration of calcium in the human body is 
much lower than the concentrations needed for stabilization purposes.  
4.2 Cell survival  
Viability of osteosarcoma cells inside alginate beads mineralized using 0.5 and 0.25mg/mL ALP was 
studied. The viability was found to be dependent on enzyme concentration. Viability of MSCs in 
mineralized beads was high throughout the time of the studies. 
Viability of osteosarcoma cells inside mineralized alginate beads by the enzymatic method was hard 
to interpret. In all experimental samples, viability was estimated between 50-90%. However, as the 
alginate beads became greatly mineralized, image acquisition on CLSM was difficult. Nonetheless, 
there seemed to be a tendency for greater survival when a lower concentration of enzyme 
(0.25mg/mL) was used compared with a higher one (0.5mg/mL) (figure 3.6 and 3.7). In addition, 
because the lower concentration facilitated image acquisition and increased bead stability, the same 
concentration was introduced when using MSCs. 
For MSCs the viability was >90% for all samples in initial experiments using 0.25mg/mL ALP 
(experiment M1, figure 3.9). However, the beads repeatedly appeared to be much less mineralized 
than with the osteosarcoma samples (figure 3.8). This might be due to a higher proliferation, and 
activity, of the osteosarcoma cells causing mineralization of the beads. To increase mineral content in 
beads with MSCs, increasing the ALP concentration to 0.5mg/mL was attempted. In this experiment 
cells showed good viability until reaching day 8 post encapsulation, when the study was ended 
(experiment M3, figure 3.13). Increasing the enzyme concentration prepared heavily mineralized 
beads (figure 3.11). At this point, image acquisition on CLSM was again a problem. Whether cells are 
all dead in the core of the bead was impossible to determine. On the other hand, the viability of the 
cells that were visible in the microscope appeared to be good (>90%).  
Before encapsulation cells continuously expressed viability >95% when studied in the light 
microscope. Nevertheless, at day 2 post encapsulation the viability seemed to have decreased 
slightly, from >95% to 90% (experiments M1-4). The osteosarcoma cells showed a grater decrease, 
particularly in beads with addition of 0.5mg/mL ALP (from >95% to 50%, figure 3.6). This might be 
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explained by the shear forces needed to mix the cell suspension in the syringe pre encapsulation due 
to the high viscosity of the alginate solution. The drop in viability in the present study is nevertheless 
better than previously reported in studies regarding the particular problem (Kong, 2003).  
Earlier studies have experienced high viability of MSCs when incorporating RGD peptides into the 
alginate beads. Weir et al reported viabilities of up to 80% during 21 days of culture when 
encapsulating MSCs in alginate beads. Weir et al also tested viability in alginate beads modified with 
calcium phosphate cement (CPC) resulting in 75% survival the same time period (Weir, 2010). Bidarra 
et al compared encapsulated MSCs that were given MSCGM and MSCDM respectively. Both samples 
maintained high viability (80-90%) throughout the time of the study (Bidarra, 2010). Evangelista et al 
also included samples without RGD peptides as controls. In these beads mouse mesenchymal stem 
cells (mMSCs) were encapsulated. No statistical significance was found between survival in RGD-
samples and controls (Evangelista, 2007). In the two latter studies they used a cell concentration 10 
fold as high as in the present study. This may contribute to higher survival as higher cell 
concentrations promotes cell interactions. However, cell survival in the present study indicates that 
cell survival is good regardless of initial cell concentration.  
4.3 Metabolic activity  
The metabolic activity of encapsulated MSCs in alginate beads was studied in experiment M4. 
Samples were tested at day 2, 7, 14 and 21 post encapsulation (figure 3.19). The metabolic activity 
was found to increase over the time of the study for all samples. From day 2 to day 7 post 
encapsulation the activity differed modestly. All samples showed an increase in activity between day 
7 and day 14. From day 14 to day 21 samples showed no or little increase.  
The minute change in metabolic activity for all samples from day 2 to day 7 could potentially be 
caused by the need for the cells to adapt to the new environment. The live/dead assay (figure 3.17 
and 3.18) revealed an increase in cell clusters from day 7 to day 14 post encapsulation. As cells were 
continuously observed growing outside the beads from day 14 the increase in metabolic activity 
could point to cell proliferation. A smaller, relative increase in samples receiving differentiation 
medium (3a/4a) could point to an end in proliferation, in favor of differentiation.  
Comparing metabolic activity between cell lines is hard, as different cell lines will behave differently 
inside alginate beads (Rokstad, 2006). However, earlier studies report an increase in metabolic 
activity, even if no proliferation is observed. This is especially evident in samples were RGD peptides 
are utilized (Bidarra, 2010). The reason for the increased activity is thought to be caused by different 
cellular functions such as cell differentiation, cytoskeleton rearrangement and synthesis of proteins. 
As actin filaments were observed in morphology studies, the increase in metabolic activity could be 
due to cytoskeleton rearrangements in the cells.  
In another study where mMSCs3 were utilized the findings suggest that alginate modified with RGD 
peptides result in higher metabolic activity. This is explained by the fact that peptides interacts with 
cells, triggering cellular actions (Evangelista, 2007).  
                                                          
3
 Mouse MSCs and human MSCs have been shown to differ somewhat in the expression of runx2 during the 
differentiation process towards osteoblast. When comparing mouse- and human MSCs the fact that they show 
different patterns in gene expression, and differences in surface receptor patters should be taken into account 
(Therese Standal, personal communication). 
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4.4 ALP assay 
ALP activity was measured at day 2 and 9 post encapsulation in MSCs encapsulated in alginate beads. 
The activity of ALP gives an indication of whether cells are starting to differentiate.  
At day 9 post encapsulation (figure 3.23) there was a statistical significant higher ALP activity in the 
two samples receiving differentiation medium (samples 3a and 4a) compared to the ones not 
receiving differentiation medium. This suggested that differentiation had indeed started in these 
samples. 
Results from day 2 post encapsulation (figure 3.22) were unexpected as the sample without added 
ALP (sample 3) showed similar results as the sample with ALP (sample 4). However, as no difference 
between the samples initially containing ALP and not containing ALP was found, suggested that the 
encapsulated ALP from the beginning of the experiment no longer was active and did not influence 
the results.  
Earlier studies have reported a maximum activity at day 7 (Matsuno, 2008), day 14 (Zhao, 2010, Weir, 
2010) and day 21 (Bidarra, 2010) post encapsulation when encapsulating MSCs into alginate beads, 
which is surprising as ALP should only be expressed early in the differentiation (Matsuno, 2008). Both 
Bidarra et al and Weir et al also tested the activity of MSCs in beads receiving basal medium. These 
showed low and constant activity. This is in accordance with the findings in the present study, as ALP 
activity of undifferentiated samples was comparable to the controls at day 9.  
4.5 Morphology 
Morphology was studied by staining the nucleus and actin filaments of MSCs inside alginate beads. In 
initial experiments with MSCs (experiment M3) cells seemed to interact with each other by 
elongation of their actin filaments (figure 3.12). In the extended experiment (experiment M4) cells 
seemed to both interact with each other, and the matrix (figure 3.20 and 3.21).  
In initial experiments (M3) cells were observed to interact with each other (figure 3.12). It seemed 
that they reach out towards each other rather than interacting with the matrix. The image in the 
figure is cross section only, so it is hard to make a conclusion. 
In the extended experiment (M4) the mesenchymal stem cells appeared to have different 
morphology in the different beads. In samples given differentiation medium, cells appeared to 
possess an elongated cytoskeleton (figure 3.20 and 3.21). Some of the elongated actin filaments 
could be explained by cells trying to interact with each other, as especially evident in figure 3.20 day 
7. However, elongations of the actin filaments were also apparent where there were no adjacent 
cells, as evident in figure 3.20, day 21 and figure 3.21 day 14. It seems that cells are indeed 
interacting with the matrix. However, not all cells in each bead had the described morphology. 
Indeed, some appeared in a round shape, interacting neither with neighboring cell nor with the 
alginate matrix. 
In samples not given differentiation medium cells appeared to exist in a round shape throughout the 
duration of the study.  
Evangelista et al (2007) showed that immobilization of mMSCs in alginate without modification with 
RGD lacked the assemblage of actin filaments, preventing interactions between cell and matrix. 
mMSCs in alginate beads modified with RGD was observed to possess elongated actin filaments, thus 
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creating a means of interacting with each other, and the matrix. This was explained by the RGD 
peptide interacting with integrins on cell membranes, directing the cell to assemble actin filaments. 
Morphology was also studied by Bidarra et al (2010). They reported that hMSCs interacted to a 
certain extent with the alginate matrix when modifying the alginate with RGD peptides. Bidarra et al 
also included control samples without RGD, and these remained in a round shape without 
interactions with the matrix. These observations lead to the conclusion that RGD peptides are 
essential for cell-matrix interactions. The findings in these articles were not confirmed in the present 
study, as cells interacted with the matrix when using alginate and CP, or alginate alone.  
4.6 Citrate treatment 
Initial problems regarding RNA isolation was found to be due to cell death caused by the citrate 
treatment used to isolate cells from the alginate beads. The more mineralized the beads were, the 
harder it was to dissolve them upon citrate treatment. This may be explained by the fact that the 
minerals seem to dissolve prior to the beads themselves. This was repeatedly observed in the light 
microscope during citrate treatments. As a consequence cells within mineralized alginate beads were 
often recovered in a lower percentage than the ones inside lesser mineralized beads.  
In the literature little is described concerning cell recovery in alginate beads. However, citrate 
treatment is the method that seems to be most frequently utilized. Some describe dissolving the 
beads in citrate for 10-40 minutes (Häuselmann, 1994, Mok, 1994, Patel, 2004), but no data exist is 
on the topic of cell survival post treatment (Cohen, 2011). For that reason, Cohen et al. (2011) 
focused on MSC recovery from alginate beads, and cell survival in different suspensions commonly 
used when working with alginate beads. Cohen et al. report observing merely 12% survival of swine 
MSCs (sMSCs) when dissolving alginate beads in citrate for 20 minutes. This coincides with the 
observations found during the present study. Furthermore, Cohen et al. tested how EDTA influenced 
cell survival if used to dissolve beads, but these results were unsatisfactory as well. These results 
indicate that novel methods for recovering cells inside alginate beads need to be uncovered. 
MSCs encapsulated in beads mineralized by the one-step method have been recovered using the 
citrate treatment at NTNU earlier. In this study the RNA quality, following the one step method, was 
repeatedly very poor (OD260/280 <<2), indicating DNA contamination (Sundrønning, 2010).  
Ultimately, in the present study, recovering of cells using the sequential citrate treatment was 
accomplished with satisfactory result. The isolated RNA were observed to be of good quality 
(260/280 > 2) (table 3.4), and PCR results proved good and reliable. Using a sequential citrate 
treatment gives RNA of good quality as cell viability is kept as high as possible (up to 30%). RNA and 
alginate is hard to separate as they are both negatively charged polymers. By avoiding extensive 
exposure of cells to citrate, cell viability is maintained at a tolerable level (i.e no RNA is free in the 
medium, which would make it hard to separate RNA from alginate in the RNA isolation procedure).  
4.7 PCR 
PCR analyses were performed after recovering RNA by a sequential citrate treatment (appendix A), 
and subsequent synthesis of cDNA. RNA was of good quality. PCR results showed that runx2 was 
expressed in MSCs encapsulated in beads heavily mineralized (experiment M3, figure 3.14). Both 
runx2 and osterix were expressed in MSCs encapsulated in mineralized/unmineralized beads, with 
and without induced differentiation (experiment M4, figure 3.25 and 3.27). 
 48 
Runx2 expression for unencapsulated MSCs and sample 3 (not given ALP) at day 2 post encapsulation 
were similar (figure 3.25). At day 2, expression in sample 4 (given ALP) was slightly higher. This 
suggests that ALP accelerated differentiation. However, none of the samples were at this point given 
differentiation medium, so the slight difference could be explained by the cell population retrieved 
from beads.  After culturing samples 3a and 4a (not given ALP and given ALP, respectively) runx2 
expression increased significantly from day 2 to day 7 post encapsulation, compared to samples 3b 
and 4b (not given differentiation medium). This suggests that the components in the differentiation 
medium indeed could penetrate the alginate beads, and thus exert their effect on the cells. Runx2 
expression remained higher in samples with differentiation medium compared with samples in 
regular medium throughout the study. One exception was sample 4b (given ALP, cultured in regular 
medium). This sample showed a continuous increase in activity reaching day 21, when the expression 
was similar to the former. This suggested that mineralization might play a role in differentiation. The 
relatively high expression of runx2 in sample 3b on day 7 could not be explained. 
Osterix expression showed greater differences between samples given differentiation medium 
compared with samples given regular medium (figure 3.27). The samples given differentiation 
medium (3a/4a) increased roughly 100- and 60-fold, respectively from day 2 to day 7 post 
encapsulation, suggesting that the MSCs were differentiating into mature osteoblasts. The 
expression continued to increase for both samples reaching day 14. At this point, osterix expression 
in sample 3a decreased slightly, whereas expression in sample 4a continued to increase until day 21 
when the study was ended.  
Samples cultured in regular medium (3b/4b) showed a comparable osterix expression profile. They 
increased 5-fold until day 14, and 10-fold until day 21 compared with the expression at day 21. This 
was surprising as they were not given differentiation medium. No apparent differences between 
mineralized and unmineralized beads were observed, suggesting that mineralization did not affect 
differentiation. On the contrary, alginate by itself, seemed to exert an effect on differentiation, but 
this was difficult to confirm. 
Osterix expression has been analyzed in a study where human umbilical cord mesenchymal stem 
cells (hUCMSCs) were encapsulated in alginate beads cultured in differentiation medium. The results 
showed that hUCMSCs had a 12-fold increase in osterix expression from day 1 to day 7 post 
differentiation culturing start. A 3-fold reduction was observed between day 7 and day 14 (Zhao, 
2010). These results differ somewhat from the results obtained in the present study. A reason for the 
difference was not found.  
4.8 SEM 
In the extended experiment (M4) beads were studied by SEM after the 21 days of culture. Both 
matrix and cells were studied (figure 3.28). Furthermore, collagen fibers were observed in pictures 
from samples receiving differentiation medium confirming results indicating that the stem cells had 
in fact differentiated into mature osteoblasts (figure 3.29 and 3.30). 
In images of alginate beads in samples without ALP (3a/3b) there were no apparent mineralization 
(figure 3.28). However, some of the beads in sample 3a appeared mineralized, as they were dark in 
the light microscope. The lack of obvious minerals observed in SEM images may be due to the 
inhomogeneously distribution of mineralization between beads. The structure of the matrix in 
sample 3a (cultured in differentiation medium) seemed less porous compared with samples 3b 
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(cultured in regular medium). This has been observed earlier in similar beads mineralized by the in 
situ method (Sundrønning, 2010). Observations of cells in the same beads revealed that only cells in 
beads from sample 3a appeared to be interacting with the matrix (figure 3.28). This supports the 
observations made in the morphology studies described above.    
In images of alginate beads in samples with ALP (4a/4b) minerals were observed to a larger extent in 
sample 4a (figure 3.28). This might yet again be explained by the small bead population studied in 
SEM. The density of minerals seemed to be higher compared with beads mineralized with the in situ 
method (Sundrønning, 2010). The cytoskeleton of cells seemed to be more expanded in cells in 
sample 4b (cultured in regular medium), compared with sample 4a (cultured in differentiation 
medium). This is also surprising as cells from sample 4b did not seem to interact with the matrix in 
morphology studies previously described.  
Bidarra et al (2010) reported cells interacting to certain extent with alginate modified with RGD 
peptides when studying them in SEM. Cell-matrix interactions in the present study appear different, 
as the filaments appeared more extended.  
Evangelista et al (2007) cultured an osteoblast cell line into alginate modified with RGD, and into 
unmodified alginate. The cell morphology was studied in transmission electron microscope (TEM). 
Osteoblasts within RGD modified alginate showed fibrils suspected of being collagen at day 3 post 
encapsulation. These fibers were never observed in unmodified beads. Additionally, osteoblast in 
modified beads had a larger number of mitochondria, probably due to increased metabolic activity, 
and had a more round nucleus, compared with cells in unmodified alginate.  
The morphology of the cells in the present study was comparable to the osteoblasts in RGD-modified 
alginate as described above, suggesting first and foremost, that they are in fact mature osteoblast. 
Secondly, it suggests that modification with RGD could be substituted with modification with calcium 
phosphate minerals. This might be a good thing as coupling of RGD to alginate have been 
problematic in the past in reproducing coupling efficiency (Westhrin, 2010). 
During preparation of the samples for SEM analysis a lot of the samples material disappeared during 
CPC. Only three or four sections of the bead were left. The pictures were, nevertheless, regarded as 
representative.  
4.9 Differentiation of MSCs in alginate beads 
Mesenchymal stem cells seemed to have differentiated into mature osteoblasts in both samples 
receiving differentiation medium, regardless of mineralization.  
 
This is especially apparent in the PCR results, where cells cultured in differentiation medium were 
found to express osterix, a specific marker for mature osteoblasts. Runx2 was showed a continuous 
and high expression. Runx2 expression and ALP activity is usually connected. The reason for the 
disagreement between these analyses could be due to differences in bead population, and sensitivity 
of the analysis. For ALP analysis only an estimate of 4000 cells were used, compared with a million in 
PCR. Furthermore, PCR is far more sensitive, suggesting that the PCR results are the most reliable.  
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The metabolic activity increased over time in culture in all samples, although less increase over time 
was observed for samples cultured in differentiation medium. As osterix expression was high in 
samples cultured in differentiation medium, the increase in activity is probably not caused by 
proliferation, as osterix is a known proliferation inhibitor (Zhang, 2008). The increase in activity could 
consequently point to differentiation. 
 
Morphology of the cells given differentiation medium appeared more osteoblast-like, as they 
contained actin filaments interacting with the matrix. Moreover, SEM images showed that collagen 
fibers were present in both samples. This further confirms the presence of mature osteoblasts. 
Minerals were observed in both samples, but in a slighter degree in beads without ALP, compared to 
samples with ALP. This suggests that ALP is not essential for mineralization, all though it speeds up 
the mineralization process significantly. Light microscopy pictures confirmed these observations, as 
samples appeared dark. 
 
Cell viability remained > 90 % up to day 21 when the study was ended. 
 
4.10 Future perspectives 
Bead stability  
Increasing bead stability would be advantageous, as methods such as mineral quantification by 
Alizarin Red-S could be accomplished. Increasing bead stability has previously been solved by 
addition of CaCl2 to the culture medium, by modification of the beads, such as addition of poly-L-
lysine or chitosan, or by adding a small amount of acrylamide to the alginate. Any of these latter 
methods could offer a potential mean of stabilizing the alginate beads. 
ALP activity 
ALP activity was measured only on day 2 and day 9 post encapsulation in the present study. ALP 
activity has previously been demonstrated to be as its maximum at day 14 and 21 post encapsulation 
as described in section 4.3 ALP activity. As ALP activity is often used together with runx2 to evaluate 
differentiation of MSCs, it could be interesting to continue to measure the activity throughout the 
period of a study. 
Cell recovery 
In order to yield sufficient cell numbers for RNA analysis the cell recovery method should be studied 
in more detail. In the present study, at best, 30 % of the cells were recovered after a sequential 
citrate treatment. Increasing the yield would decrease the work-load and -time significantly. This is 
due to the fact that a lower cell number would be much more easily up-cultured in vitro. 
Furthermore, smaller amounts of cells would be cost effective because smaller amounts of reagents 
(such as MSC medium) would be needed. As of now, citrate and EDTA seem to be the standard 
reagents for cell recovery purposes. As the beads in the present study are of poor stability, reagents 
with phosphate ions could be an interesting alternative. In addition, such reagents, for cell recovery, 
should not be harmful to the cells. 
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Cell adhesion 
To promote both adhesion and bone formation, including RGD peptides in the immobilization matrix 
seem to be a good alternative. They have been shown to promote both adhesion and direct 
differentiation of myoblasts into skeletal muscle cells by varying M:G ratio in the alginate and density 
and sequence of the peptides (Rowley, 2001).  For bone cell adhesion RGD seem to be a good 
candidate. This peptide has been shown to enhance adhesion of bone marrow stromal cells to HA 
composites (Durrieu, 2004). Furthermore, RGD is shown to drastically increase bone formation in 
vivo in alginate beads (Augst, 2006). As a bonus, coupling of RGD peptides might be beneficial, as the 
binding could increase bead stability.  
Confirm differentiation 
Occurrence of mature functioning osteoblasts should be further confirmed by testing gene 
expression of marker genes specific for mature osteoblasts, such as OCN and BSP (Zhang, 2010). OCN 
levels can also be measured by ELISA by measuring OCN concentration in the culture medium. This is 
due to the fact that osteoblasts excrete the protein. In addition collagen gene markers should be 
analyzed to support the observations of collagen in beads by SEM analysis.  
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5. Conclusion 
Enzymatic mineralization of alginate beads was found to be a cell friendly way of mineralizing 
alginate beads. Mineralization of the beads was observed in the light microscope, by visual 
inspection, as well as by SEM. Cell viability remained high when using a concentration of 0.25mg/ml 
ALP. Osteosarcoma cells were used as model cells in initial experiments. They proved to be good for 
optimizing the enzymatic mineralization method, but behaved differently compared with 
mesenchymal stem cells in terms of viability, and activity. Alginate beads were unstable and needed 
addition of CaCl2 for stabilization purposes. An improved method for cell recovery was prepared. This 
sequential citrate treatment led to successful isolation of RNA with good quality. 
Mesenchymal stem cells receiving differentiation medium were observed to differentiate into 
mature osteoblasts within the beads. This was confirmed by gene expression analysis, cell 
morphology, ALP activity and the presence of collagen. Proliferation of MSCs in beads was 
additionally observed, although only to a small degree. Metabolic activity measurements confirmed 
little cell proliferation, nor cell death. Cell morphology in differentiated samples was recognized by 
showing elongated actin filaments, compared with the ones cultured in regular medium. This 
suggested that the cells were able to interact with the matrix. The occurrence of collagen fibers in 
SEM images further confirmed the presence of mature osteoblasts.  
Samples cultured in regular medium with or without added ALP showed an increase of osterix 
expression until day 21 when the study was ended. This was surprising, as it inferred that the alginate 
matrix itself might influence differentiation of MSCs into osteoblasts, and that mineralization has 
little effect. 
Encapsulating mesenchymal stem cells into alginate beads mineralized by the enzymatic method is 
cell friendly, and allows the cells to differentiate into mature osteoblast when cultured in 
differentiation medium. Alginate without minerals seemed to influence differentiation to a certain 
extent, suggesting that minerals are not needed for differentiation to occur. The minerals do, 
however, speed up following mineralization of the beads.  
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Appendix A   Citrate treatment 
No cells were left after the citrate treatment in the experiment described in section 3.1 Initial 
experiments. At first, it was hypothesized that the centrifugation was the major cause for the loss of 
cells. As it was discovered that this was not the case further steps had to be taken in order to 
optimize the treatment to increase the yield of recovered cells. 
A.1 Citrate treatment in 2D 
Further studies on citrate treatment were conducted. U2OS cells in culture were added 10 mL citrate, 
and after 10 minutes 10mL trypan blue were added to give an impression on cell survival post 
treatment (figure A.1). 
 
 
 
Pre citrate 
treatment 
  
 
 
 
Post citrate 
treatment 
  
Figure A.1. Osteosarcoma cells pre/post citrate treatment in 2D.  The left picture was taken with a 10X objective, and the 
right with a 40X objective. 
As it was impossible to quantify cell survival both pre and post treatment, all that could be drawn 
from this experiment was that the morphology had changed. Pre citrate treatment the cells were 
stretched out, and afterwards they became more compressed. 
A.2 Citrate treatment of Osteosarcoma cells encapsulated in alginate beads 
In another experiment mineralized beads with osteosarcoma cells were split in two and exposed to 
citrate in volumes of 5 and 20mL, respectively. In figure A.2 is an illustration as to how mineralized 
the beads were at the time of citrate exposure. 
 
Pictures during the citrate treatment were taken every 5 minutes and the results are given in figure 
A.3.  Cells were counted before treatment and after 15 minutes of citrate exposure.  
 
Figure A.2. Osteosarcoma cells encapsulated in alginate beads at day 7 post encapsulation. The image is magnified 40X. 
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Time Cells added 20 mL of 
citrate  
Cell survival Cells added 5mL of 
citrate 
Cell survival 
 
0 
 
Viability: 
55%  
~ 400.000 live 
cells 
 
Viability: 
55%  
~ 400.000 live 
cells 
 
5 
 
 
 
 
 
10 
 
 
 
 
 
15 
 
Viability: 
30%  
~70.000 live 
cells 
 
Viabillity: 
45% ~180.000 
live cells 
 Addition of 20mL citrate 
(7min) 
Viability: 5% 
~10.000 live 
cells 
Addition of another 5 
mL citrate 
 
 
15 
  
 
 
 
20 
  
 
 
 
25 
  
 
 
 
30 
  
 
Viability: 
10%  
~30.000 live 
cells 
Figure A.3 Pictures of beads with encapsulated osteosarcoma cells undergoing citrate treatment. The pictures were taken 
every 5 minutes. Magnification is 40X. 
Seeing that more cells were left after addition of 5mL of citrate compared with 20mL, this volume 
was selected for further studying. Additionally, as 180.000 live cells were present after 15 minutes of 
treatment a new method was set up with the goal of retrieving these cells before addition of more 
citrate to dissolve the remaining beads. 
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A.3 Sequential citrate treatment of encapsulated osteosarcoma cells at d13 
Osteosarcoma cells encapsulated in beads mineralized with 0.25 and 0.5 mg/mL ALP were prepared 
as described in table 2.1 experiment U3. A 50:50 relationship between beads with different ALP 
concentrations was prepared. The amount of beads should account for 550.000 live cells. Every 6 
minutes after addition of 5mL citrate the beads/bead particles remaining were allowed to segregate 
and the suspension left was pipette off and centrifuged at 1000g for 3 min. This method will 
henceforth be referred to as the sequential citrate treatment. The cells were counted in an 
automated cell counter. Pictures taken during the citrate treatment, the survival of the cells and the 
total number of live cells are given in figure A.4. 
Time after addition of 
citrate (min) 
Image Survival (%) Live cells 
0 
 
80 550.000 
6 
 
60 240.000 
12 
 
73 580.000 
18 
 
60 130.000 
24 
 
77 720.000 
30 
 
32 104.000 
36 
 
15 300.000 
Figure A.4 Osteosarcoma cells encapsulated in alginate beads during citrate treatment to retrieve cells. 
 
Clearly this is wrong. Starting out with 550.000 cells, would by no means result in the recovery of 
about 2 millions. It was suspected that the cell counter could not tell the difference between bead 
fragments and living cells.  
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A.4 Improving sequential citrate treatment experiment 
For further assessment a new experiment was set up where 2 million osteosarcoma cells were 
encapsulated in alginate beads mineralized with 0.25mg/mL ALP. The main goal was to count the 
beads in both the automated cell counter and manually in Burker counting chambers. The survival of 
the cells inside the beads pre citrate treatment was assessed by live/dead assay and CLSM before 
starting the treatment. The live/dead images and light microscope pictures are given in figure A.5. 
 Osteosarcoma cells in alginate beads given 0.25mg/ml ALP 
 
 
 
 
 
Day 2    
 
 
 
 
 
Day 4 
 
  
 
 
 
 
 
Day 7 
 
  
Figure A.5 U20S encapsulated in alginate beads mineralized with 0.25mg/mL ALP at day 0, day 3 and day 7. The images to 
the left are taken with a light microscope to give an impression on the mineralization of the beads. The middle picture is 
a CLSM cross section, and the image to the right is a 3D projection of a z stack. Live cells appeared green, whilst dead 
cells appear red. The life image is magnified 40X, and the two right pictures are magnified 100X. 
Some of the beads appeared to crack open as they waited for CLSM assessment. This had been 
observed in earlier experiments and was thought to be due to the phosphate in the PBS. 
The citrate treatment on these cells resulted in 0 % recovery when counted manually, thus verifying 
the hypothesis that the automated cell counter cannot distinguish live cells from bead fragments.  
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A.5 Sequential citrate treatment of encapsulated mesenchymal stem cells 
Following, the beads were treated with citrate to attain the cells within. An amount of beads that 
accounts for 2 million cells was prepared and 5mL of citrate was added. The suspension was gently 
mixed during the six first minutes, and at that point the beads which remained intact were allowed to 
descend. The rest of the suspension was pipetted off and centrifuged for 3 min at 1000rpm. The 
remaining beads was given another 5mL of citrate and further mixed. Results are given in figure A.6. 
 
Time (min) Picture Survival (%) Number of live cells 
 
 
0 
 
 
 
90 
 
 
260.000 
 
 
6 
 
 
 
90 
 
 
215.000 
 
 
8 
 
 
 
0 
 
 
0 
 
 
   Sum 475.000 (~25% recovery) 
Figure A.6 Pictures taken during the citrate treatment, the survival of the cells and the total number of live cells during 
citrate treatments on MSCs encapsulated in alginate beads mineralized with 0.25mg/mL ALP. 
As the beads were poorly mineralized the citrate treatment went fast. Probably more heavily 
mineralized beads will be harder to dissolve. 
The recovered cells were subsequently incubated in a culture flask for 24 hours, and counted again 
the following day. At this point about 300.000 cells were left, and all were prepared for RNA analysis. 
The eluted RNA was quantified using NanoDrop. Unfortunately, only 180ng was recovered. 
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A.6 Survival of mesenchymal stem cells in citrate  
Recovering cells from alginate beads are usually accomplished using citrate or EDTA. However, cell 
yields in the present study proved to be unsatisfactory. Little is described in the literature on the 
subject. In 2011 Cohen et al. report observing merely 12% survival of swine MSCs (sMSCs) when 
dissolving alginate beads in citrate for 20 minutes. How cells were affected by citrate, EDTA and 
calcium chloride is given in figure A.7. PBS was initially used as a control. Surprisingly, PBS also 
seemed to decrease cell viability by roughly 20%. An explanation for this was not found. 
 
 
Figure A.7 Survival of mesenchymal stem cells exposed to PBS, Sodium Citrate, calcium chloride and EDTA (Cohen, 2011). 
 
Summarized, it seems that osteosarcoma cells respond poorly to citrate treatments, whereas MSCs 
appear to possess a superior tolerance. Finally, the parameters for the sequential citrate treatment 
(volume of citrate, time of exposure, number of parallels) need to be tailored for each experiment 
depending, primarily, on how mineralized the beads are.  
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Appendix B   Alizarin Red-S  
Alizarin Red can be used to study both the degree of mineralization, and the distribution of minerals 
throughout the beads (Puchtler, 1969). The method is based on dying the calcium levels compared to 
assaying inorganic phosphate. This is an advantage as a lot of phosphate is present without being 
part of the mineralization precipitates (Gregory, 2004).  Two possible mechanisms for ARS staining 
are given in figure B.2. It seems that the salt form is the salt form is the one mostly observed (Ibsen, 
2010). ARS is not specific for calcium ions, but will react with a range of ions, resulting in different 
colored precipitates (Puchtler, 1969). 
 
Figure B.2 Two proposed mechanisms of Alizarin Red S absorbed onto hydroxyapatite. Neither of the two involves the 
sulphuric group, as has been believed previously (Moriguchi, 2003). 
Attempts were made in order to determine the mineral content in alginate beads. Firstly, a method 
used for beads mineralized by the in situ one step method was attempted.  
Method 1: A few beads were transferred from the culturing flask to a sterile tube. Next, 10 beads 
were added to a 24 well plate, using three parallels. 250µl of medium was added to each well.  
Subsequently, formaldehyde (FAH, 4%) was added to fixate the beads, after which the plate was put 
on ice for ten minutes. The samples were washed once with 1mL PBS and once with saline solution. 
At this point 40mM Alizarin Red (500µl) was added and the plate was incubated for 30 min with 
gentle agitation at RT. Following, the beads were washed twice with sterile water, and incubated for 
15 min with 500ul PBS. The PBS was subsequently removed and 10% CPC/10mM sodium phosphate 
buffer (250ul, pH=7) was added. The plate was incubated for one hour with gentle agitation.  A 
dilution series was made consisting of duplicates of 800, 400, 200, 100, 50, 25, 12.5, and 0 µM ARS, 
and their absorbance at 570 nm was measured.  
 
This method could not be completed as no beads were left in the wells after the ARS-S treatment. 
Initially, this was thought to be caused by the handler pipetting up beads whilst washing the samples 
or by the poor stability of the beads, making them crack open. Consequently, the method was 
attempted once again, this time with extremely careful pipetting. The samples were observed every 
5 minutes in the microscope during ARS-S staining. Not surprisingly, no beads, or a lot of alginate 
particles were observed in the wells, thus confirming that bead stability was again an issue.  Some 
beads remained intact and pictures were taken in the light microscope (figure B.3).  
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Figure B.3. Light microscope picture taken during initial experiments on ARS-S. The sample is sample 2, that is 
mineralized and without cells. For the samples containing cells, only MSCs remained in the wells and no alginate particles 
could be observed. 
Clearly, the beads need to be stabilized during staining. This proved to be hard as ARS-S is not specific 
for calcium ions, but reacts with other cations as well. As a consequence, Ba2+- ions were added to 
sterile water, and this solution was used as the sole washing agent in the next experiment. This 
means that PBS and saline solution were discarded. Again the samples were kept under close 
observations in the light microscope. Following pictures were taken after roughly 17 minutes, when 
the plate was taken off the agitation apparatus (figure B.4).  
 
Figure B.4: Light microscope pictures taken at t=17 during ARS-S staining. The left picture shows sample 4b, mineralized, 
with cells and undifferentiated. The right picture shows sample 4a, mineralized, with cells and differentiated.  
A lot of precipitates were observed in the wells. These were thought to be of ARS-S/Ca2+ and ARS-
S/Ba2+.  After trying to wash the cells, all were lost. To test whether the ARS-S precipitated with any 
other of the solution a small test was set up where ARS-S was added to wells with different solution 
and left on gentle agitation for 30 minutes. The results are given in table B.1. 
Table B.1 Reaction of ARS-S with different solutions. ARS-S was added to wells containing the mentioned chemicals, and 
left under gentle agitation for 30 minutes. 
Solution Precipitates observed 
Sterile water No 
Tap water No 
Saline solution Yes 
Solely ARS-S No 
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After seeing that ARS-S did not react with tap water, a new experiment was set up, based on another 
method used for beads mineralized by the in situ method. Additionally, the beads were kept in 
eppendorf tubes until ARS-S staining and washing was completed, that is prior to adding CPC.  
Method 2: Approximately 50 beads were transferred to eppendorf tubes, fixated with FAH in the 
fridge for four days. Beads for consequently washed three times with tap water before ARS-S (500µl) 
were added to each tube. Samples were left on gentle agitation for 20 minutes before they were 
extremely carefully washed three times with tap water.  Next, samples were added to a 24 well plate 
in three parallels and light microscope pictures were taken after washing (figure B.5). Subsequently, 
10% CPC/10mM sodium phosphate buffer (250ul, pH=7) was added, and the plate was left on gentle 
agitation for one hour. At this point, the solution without beads was transferred to a 96 well plate for 
absorbance measurements.  A dilution series was made consisting of duplicates of 800, 400, 200, 
100, 50, 25, 12.5, and 0 µM ARS. All samples were tested in duplicates.  
 
Figure B.5 Images from ARS-S. From the left; Sample 1 (unmineralized and without cells); sample 2 (mineralized without 
cells); Sample 3a (unmineralized with cells); sample 4a (mineralized with cells). Images are taken after staining with ARS-
S and careful washing in tap water. 
It was apparent that the beads were not washed as thoroughly as they should have been. This was 
again due to the poor stability of the beads. Consequently results obtained from this experiment are 
not as viable as they need to be to make a definite conclusion on mineral content. Nevertheless, 
results and the standard curve are given in figure B.6 and B.7. 
Linear regression of the standard curve yielded the formula y= 0.0012X + 0.0375 (R2=0.9997). This 
formula was used to calculate ARS-S concentration in the samples.  
 
The calculated concentration reveal that the samples with cells given mineralization medium were 
higher compared with the samples not given mineralization medium. Conversely, this difference is 
not observed in controls, as sample 1 (unmineralized without cells) is calculated to having higher 
ARS-S concentration compared with sample 2 (mineralized without cells). No statistical significant 
differences were observed.  
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Figure B.6. Standard curve based on readings from the dilution series of ARS-S.  
 
 
Figure B.7 Mineral content of alginate beads. Samples include; unmineralized beads without cells (Samples 1); 
mineralized beads without cells (sample 2); unmineralized differentiated beads with cells (sample 3a); unmineralized 
undifferentiated beads with cells (Sample 3b); mineralized, differentiated beads with cells (Sample 4a) and mineralized, 
undifferentiated beads with cells (Sample 4b). 
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